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CHAPTER 1 
PREFACE AND GENERAl INTRODUCTION 
J.A.H. Bos 
. 9 . 
PREFACE 
It is established that in a wide variety of acute and chronic lung diseases the integrity 
of the alveolar-capillary membrane is altered. Increased permeability of the barrier is 
thought to cause increased filtration of fluids and proteins into the alveoli and 
increased absorption of inhaled substances into the blood stream. This can eventually 
lead to impaired gas exchange and, therefore, deterioration of tissue oxygenation. 
Attempts to elucidate the nature of changes occurring in the alveolar-capillary barrier 
has led to increasing research with radio-labelled tracer molecules, such as 
technetium-99m-labelled diethylene triamine pentaacetic acid ('""'Tc-DTPA) and 
technetium-99m-labelled human serum albumin r'"'Tc-HSA), in order to measure the 
permeability of this membrane. 
The alveolar-capillary membrane consists of lour layers, namely; the alveolar 
surfactant layer, the alveolar ep~helium, the interstitium with basement membrane, 
and the vascular endothelium. It is generally agreed that the epithelium is the main 
rate-limiting factor in determining permeability and, therefore, limiting the ability of 
different solutes to transfer across this barrier. 
Results of recent research indicate that the alveolar surfactant layer may also be a 
rate-limiting factor for solutes and, therefore, is of importance to the permeability of 
this membrane. This thesis focuses on the significance of the surfactant layer on 
permeability measurements with radio-labelled materials and also investigates how 
different medical interventions, such as artificial ventilation and inhalation 
anaesthetics, influence permeability of the alveolar-capillary barrier when measured 
with the described techniques. In addition, the effects of cigarette smoking on 
surfactant function and ssmTc-DTPA clearance was studied in humans. 
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The thesis comprises seven manuscripts: one review describing the effects of artificial 
ventilation on the pulmonary surfactant system and six manuscripts presenting 
original work. 
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OVERVIEW OF THE STUDY 
This thesis consists one review and six studies in which the role of the pulmonary 
surfactant system on clearance measurements of pulmonary deposited 99"'Tc-DTPA 
and 99"'Tc-HSA is investigated. 
In chapter 2. on-going research concerning the effects of artificial ventilation on lung 
mechanics in general and the pulmonary surfactant system in particular is reviewed. 
Special attention is given to those ventilator settings which might damage the lungs 
and the alveolar surfactant layer and a possible pathophysiological mechanism is 
presented. 
It is thought that ventilator settings which prevent large pressure-volume swings 
during the breathing cycle might preserve the lungs, the surfactant system and 
prevent the occurrence of ventilation-induced damage. This becomes more crucial 
whenever already damaged and stiff lungs are mechanically ventilated. Chapter 3 
describes a study performed in rabbits with surfactant deficient, uncompliant lungs 
in which high frequency jet ventilation (HFJV) at 2 and 15 Hz is investigated. These 
two ventilator settings are compared to a standard method of ventilation in healthy 
and sick animals. 
Chapter 4 presents a study in which the influence of an experimentally increased 
surfactant content on "mTc-DTPA clearance measurements is investigated. This was 
achieved by intravenous administration of Ambroxol® or exogenous natural surfactant 
instillation in healthy animals. Both methods are accepted techniques to increase 
alveolar surfactant content. At the same time, the effects of standard ventilator 
settings are compared with settings involving large tidal volumes. 
The sensitivity of 99mTc-DTPA clearance measurement is well known and this 
technique was compared with blood gas tension measurement. The purpose of this 
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study was to investigate whether blood gas tension measurement under conditions 
of surfactant deficiency and artificial ventilation sufficiently characterises lung damage 
and to compare this technique with "mTc-DTPA clearance rate measurement 
(chapter 5). 
Although 99mTc-DTPA is often used for permeability measurements, it has been stated 
that 99mTc-DTPA is too small a molecule to be able to discriminate between 
intermediate and severe lung damage. This is why it has been advocated to use 
larger tracer molecules, as for instance, albumin. This study describes the effects of 
lung lavage and subsequent tracheal exogenous surfactant replacement on 
permeability measurements in rabbits using 99mTc-labelled-human serum albumin 
("9mTc-HSA), instead of "mrc-DTPA (chapter 6). 
Patients (especially COPD patients) anaesthetised with inhalation anaesthetics are 
susceptible to post-operative complications as, for instance, atelectasis, decreased 
lung compliance and decreased total lung volume, which may in turn necessitate 
prolonged mechanical ventilation. The hypothesis is that these anaesthetics influence 
the integrity of the alveolar-capillary membrane and the surfactant system in 
particular. In this study halothane anaesthesia was compared with barbiturate 
anaesthesia under two different oxygen concentrations with the "mTc-DTPA clearance 
method lor measuring alterations in permeability of the alveolar-capillary membrane 
(chapter 7). 
Chapter 8 comprises a study performed in humans on the pulmonary clearance of 
99mTc-DTPA in non-smokers and smokers. Clearance of the tracer is known to be 
increased with smoking but the exact mechanism is not yet known. In this study, the 
technique of 99mTc-DTPA clearance measurement is compared with other methods 
of testing alveolar-capillary permeability and correlated to certain parameters involving 
the pulmonary surfactant system. 
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INTRODUCTION TO THE TECHNIQUE 
The alveolar-capillary barrier, consisting of four layers (alveolar surfactant layer, 
alveolar epithelium, interstitial space with basement membranes and vascular 
endothelium), is important in allowing free diffusion of gases and restricting the 
transfer of water, solutes and proteins across the barrier. The integrity of the alveolar-
capillary membrane can thus be assessed by measuring its permeability to 
molecules. This feature can easily be explored by using radio-labelled solutes and 
monitoring their transfer across the membrane into the blood stream and their 
subsequent clearance from the lung. 
Current evidence indicates that the epithelium (rather than the endothelium and 
interstitium) is primarily responsible for restricting solute transport across the 
membrane. Its resistance is at least ten times greater for solutes with a molecular 
weight ranging from 1 0 - 1 00,000 dalton than that of the endothelium (the equivalent 
pore radii calculated from physiological studies are around 0.6-1.0 nm lor the 
epithelium, and around 4.0-5.8 nm or more for the endothelium) [Gorin and Stewart, 
1979; Taylor and Gaar, 1970; Staub, 1974] and permeability measurements with 
solute clearance reflect mainly epithelial permeability. 
A non-invasive, accurate method lor measuring permeability of the alveolar-capillary 
barrier was developed by Rinderknecht and Taplin [Rinderknecht et a!, 1977] and 
involved pulmonary clearance rate measurements of aerosolised and subsequently 
inhaled and deposited technetium-99m-labelled diethylene triamine pentaacetic acid 
("9'"Tc-DTPA). In brief: a radio-labelled tracer molecule is administered to the lung in 
an aerosol and deposited activity over the lungs is subsequently measured by a 
sodium iodide scintillation probe or gamma camera. The clearance rate of the tracer 
from the lungs reflects the permeability of the alveolar-capillary barrier. 
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Clearance rate calculation 
After establishing sufficient activity in the lungs, the count rate can be measured by 
using, for instance as in our studies, a gamma camera. Gamma camera images are 
obtained in successive 1-minute frames for the collecting period, stored in 64 x 64 
images matrix and in a computer (Digital PDP 11/34, Maynard, USA). Data from the 
clearance measurement can subsequently be analysed by selecting a region of 
interest, which may be only a part of the lung, or both lungs. A time-activity curve is 
generated, being a plot of radioactivity on a logarithmic scale against time on a linear 
scale. This yields a line whose negative slope is the clearance rate, commonly 
referred to as the k value. The course can be described according to the equation: 
where N is the count rate at any time t, and N0 is the count rate at time t = o. The 
rate constant k (min-') for the clearance oi 99"'Tc-DTPA from the lungs can easily be 
converted to a hall-life (f») of the tracer in the lung, which is the time taken for the 
initial number of counts to fall by half. The T» is more widely used and understood 
than the k value. The conversion equation is as follows: 
T'h = 0.693/k ( = ln2/k) -
The clearance rate k as a percentage per time is obtained simply by multiplying k by 
100%. A correction should be made lor radioactive decay of the radionuclide during 
the study time, which may be performed on individual data points or on the resulting 
curve. 
The need for correction of intravascular and tissue accumulation of ''"'Tc-DTPA 
during pulmonary clearance measurements is a point of controversy between 
different investigators. Some have stated that background correction is absolutely 
necessary and constitutes a significant refinement of the technique [Huchon, 1986; 
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Barrowcliffe and Jones, 1987 and 1988; Jones et al, 1980]. The correction factor is 
determined from relative changes in activity in an area of the thigh or shoulder and 
in the chest alter an intravenous injection of ""'Tc-DTPA. 
Others, however, state that the transfer rates of "mTc-DTPA from the blood into and 
out of muscular tissue are not necessarily the same as those from blood into and out 
of the lung tissue. Therefore, changes in blood or thigh activity are not accurate 
indices of the contribution of thoracic blood and tissue to the background activity 
observed in the lung fields [Oberdorster et al, 1986]. Some showed that background 
activity constituted only a small percentage of the total amount of activity and 
concluded that background correction is not necessary [Rizk et al, 1984; Oberdorster 
et al, 1984; O'Brodovich and Coates, 1987]. The influence of background corrections, 
however, becomes greater at higher clearance rates. 
A consensus, however, seems to be reached at the latest NHLBI workshop [Staub 
et al, 1990] where it was stated that background corrections are not necessary when 
the data collecting period does not exceed 20-30 min alter aerosol inhalation. Data 
collecting periods longer than 30 min may require background correction. 
The duration of insufflation or inhalation of the aerosol should be minimised (3-4 min 
maximum) lest an initial fast component of the clearance be masked. In normal lungs, 
this factor is not a problem where clearance rates follow a monophasic course and 
are relatively slow (independent of duration of monitoring). In abnormal lungs, 
however, clearance curves can have biphasic characteristics and curve-stripping 
procedures have to be applied in order to obtain a more detailed mathematical 
analysis. In some pulmonary disorders bi-phasic curves are produced when 
monitoring for more than 1 0 min. Biphasic (biexponential) clearance curves for 99mTc-
DTPA indicate that different lung regions have different clearance rates and bi-phasic 
clearance curves are considered to be almost certainly abnormal. 
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Studies have shown that radioaerosol clearance rates from the larger airways, 
bronchi, trachea and nasal epithelia are significantly slower than that of the alveolar-
capillary membrane and thus can influence clearance rate measurements on alveolar 
level [Barrowcliffe et al, 1 987; Greiff et al, 1990]. In part this phenomenon could be 
explained by the fact that 99mTc-DTPA can bind to the mucus layer overlining the 
broncho-tracheal epithelium [Cheema et al, 1988] or by the physically greater 
diffusion distance of the tracer to the blood [Oberdorster et al, 1986]. 
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CHAPTER 2 
EFFECT OF DIFFERENT VENTILATOR SETTINGS ON LUNG 
MECHANICS: WITH SPECIAL REFERENCE TO THE SURFACTANT 
SYSTEM 
J.A.H.Bos and B.lachmann 
Dept. of Anaesthesiology, Erasmus University Rotterdam, The 
Netherlands 
. 25. 
INTRODUCTION 
Since its introduction for clinical routine use some 40 years ago, artificial ventilation 
has proven to be a life-saving method or therapy in intensive care but also remained 
a topic of much discussion and controversy because artificial ventilation involves a 
disturbance to normal cardiovascular and respiratory function [1, 2]. 
It is also established that artificial ventilation can lead to decreased lung compliance 
and dysfunction ol gas exchange. Even more important is that artificial ventilation, 
which is generally considered to be a supportive therapy, can by itself lead to 
formation of atelectasis, pulmonary oedema, pneumonitis and fibrosis (for review: see 
Table). To date, no adequate explanation of the pathophysiologic basis of all these 
changes due to artificial ventilation has been documented. However, there is 
evidence that some of these changes are induced by alterations to the surfactant 
system. These latter findings have stimulated ongoing extensive research in this area 
in an attempt to explain the side effects of artificial ventilation and to find improved 
methods of artificial ventilation in which these effects are minimised. 
This paper gives a review of studies in which surfactant or surfactant-dependent 
functions have been investigated in combination with artificial ventilation, and what 
the immediate effects are ol the ventilator setting used. 
Firstly, the normal surfactant functions and the methods used for in vivo 
characterization of the surfactant system will be briefly described; secondly the 
influence of artificial ventilation on these functions will be discussed. 
SURFACTANT FUNCTIONS 
The normal physiological functions of the pulmonary surfactant system include: 
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a) Mechanical stabilization of lung alveoli 
The integrity of the surfactant system of the lung is a prerequisite for normal 
breathing with the least possible effort. Surfactant produces this effect by decreasing 
the surface tension of the interface between the alveoli and air. This provides an 
explanation as to why we have to generate a pressure of only 4-8 em H20 during 
each inspiration, whilst at the air-liquid interface only the surface tension of the 
plasma is present and then a pressure of 25-40 em H2 0 (depending on the radius of 
the alveoli) has to be generated for each inspiration. This is a well-known symptom 
in immature newborns with respiratory distress syndrome (RDS) and in adults with 
respiratory failure. In alveoli of different radii, an equal lowering of surface tension 
would not, however, produce stabilization of the alveolar system. It would, according 
to the law of Laplace (P= 2ajr; P= pressure in the bubble, a = surface tension, r 
= radius of the bubble), lead instead to the collapse of the smaller bubble or alveoli, 
and to their emptying into the larger ones. Since alveoli in vivo do not exhibit such 
behavior, one may conclude that the second remarkable quality of the alveolar lining 
layer is that it can change the surface tension, dependent on the size of the alveoli. 
b) Stabilization of small airways 
As early as 1970, Macklem and coworkers drew attention to the significance of 
stabilization of the peripheral airways by surfactant and hinted that its lack might 
cause airway obstruction or collapse of the small bronchioli with air trapping [3]. This 
was shown in an animal model in our laboratory in which the bronchial surfactant 
was damaged and it was demonstrated that the pressure needed to open up 
collapsed bronchioli is approximately 20 em H20. In the same study it was also 
demonstrated that severe impairment of bronchial surfactant can be successfully 
treated with exogenous surfactant replacement [4]. Besides its role in mechanical 
stabilization, bronchial surfactant also has a transport function for mucus and inhaled 
particles. This has been proven, in vitro in a study showing that particles on a surface 
film move only in one direction if the surface film is compressed and then dilatated -
comparable to the compression and expansion during inspiration and expiration [4, 
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5]. Further, bronchial surfactant also acts as an antiglue factor, preventing the 
development of large adhesive forces between mucus and the bronchial wall [6]. 
c) Protection against lung oedema 
Another function of the pulmonary surfactant system is stabilization of the fluid 
balance in the lung and protection against lung oedema [7]. In general, alveolar 
flooding will not occur as long as the suction force in the pulmonary interstitium 
exceeds the pressure gradient generated by surface tension in the alveolar air-liquid 
interface. Since the pressure gradient is inversely related to the radius of the alveolar 
curvature there is, for each combination of interstitial resorptive force and average 
surface tension, a critical value for surface tension and alveolar radius, below which 
alveolar flooding occurs. 
FUNCTIONAL CHANGES DUE TO "DISTURBED" SURFACTANT SYSTEM 
When considering the physiologic functions of the alveolar-bronchial surfactant 
system it can easily be understood that alteration in its functional integrity will lead 
to [8]: 
decreased lung distensibility and thus to increased work of breathing and 
increased oxygen demand by the respiratory muscles 
atelectasis 
transudation of plasma into the alveoli with decreased diffusion lor oxygen 
and C02 
enlargement offunctional right-to-left shunt due to perfusion of non-ventilated 
alveoli (the v. Euler-Liljestrand reflex does not "work" in surfactant deficient 
alveoli) resulting in hypoxemia and acidosis. 
METHODS FOR IN VIVO INVESTIGATION OF THE SURFACTANT SYSTEM 
The methods used to investigate the integrity of the pulmonary surfactant system in 
vivo include: pulmonary compliance measurements, Technetium-99m-diethylene 
triamine pentaacetic acid ("'mTc-DTPA) clearance rate measurement and, indirectly, 
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via monitoring of blood gases. 
Pulmonary compliance measurements 
The fact that the surfactant system is responsible for a half to two-thirds of the total 
retraction force of the lungs, makes lung mechanic studies very important. Moreover, 
recording of pressure-volume (P-V) diagrams is the only direct in vivo test for 
characterization and indication of damage to the surfactant system. To quantify these 
changes in the P-V diagram, different indices for both the inspiratory loop and 
expiratory loop were introduced [9, 10, 11]. However, in some pathological changes 
in the lung the expiratory loop cannot be used for characterization of the surfactant 
system e.g. if there is a combination of surfactant deficiency with a massive alveolar 
oedema, part of the oedema fluid may block the airways during expiration, resulting 
in air trapping: this can mistakenly be interpreted as a high expiratory stability. 
Furthermore, the P-V diagram enables differentiation between surfactant deficiency, 
pulmonary oedema, pneumonia and fibrosis. For example, when it is established that 
the cause of decreased lung compliance is due to surfactant deficiency, it is still 
possible to open up the lungs by application of a very high inspiratory pressure and 
keep them stable during expiration by a high positive end-expiratory pressure (PEEP). 
A similar situation arises in lungs with oedema or pneumonia, but due to the fact that 
these lungs are filled by plasma or exudate, the total volume which can be forced in 
at a certain pressure will be less than that of a purely surfactant-deficient lung. To 
differentiate between different types of restrictive lung diseases eg. pneumonia and 
fibrosis, it is necessary, additionally, to evaluate blood gases at different intra-
pulmonary pressures. An increase of PEEP or mean airway pressure in a pneumonia 
lung will always be followed by an increase in Pa02 whereas in case of fibrosis Pa02 
will decrease or will not change. 
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99mTc-DTI'A clearance measurement 
''mTc-DTPA is a small (molecular weight 492 dalton) water-soluble molecule which, 
alter deposition on the alveolar surface, is transferred into the blood stream across 
various biological barriers. These barriers are: the surfactant layer, the alveolar 
epithelium, the basal lamina layer and the endothelium. Clearance of 99mTc-DTPA from 
the lung measures the overall permeability of these layers. When 99~c-DTPA is 
administered via an air jet nebulizer as an aerosol whose particles favour alveolar 
deposition, a gamma camera is used to measure the amount of activity in the lungs 
over a certain period of time. Alter measurement, clearance cuNes can be analysed 
in freely-selected lung regions. This 99~c-DTPA clearance technique has proven a 
very sensitive and non-invasive method to study the integrity of the pulmonary 
surfactant system. 
It has been demonstrated that the 99~c-DTPA clearance rate depends mainly on the 
functional integrity of the surfactant system: lungs with a damaged surfactant system 
are known to have a very high clearance rate [12, 13, 14]. 
Surfactant system and arterial oxygen tension (l'aO,) 
Measurement of Pa02 is an easy to obtain indirect parameter from which conclusions 
can be drawn about the integrity of the surfactant system. If a connection is 
suspected between presence of hypoxemia and decreased function of the pulmonary 
surfactant system, it can be established by letting the patient breathe 1 00% oxygen. 
In healthy lungs, Pa02 should increase to at least 500 mm Hg; whereas with a 
damaged surfactant system Pa02 will be < 500 mm Hg, due to atelectasis and 
intrapulmonary shunting. If the application of continuous positive airway pressure 
(CPAP) or PEEP leads to an improvement of Pa02 and this improvement is 
dependent on the height of the end-expiratory pressure it means that collapsed 
terminal airways andjor alveoli, due to the damaged surfactant system, have been 
re-opened. This also means that each tendency of alveolar collapse and atelectasis 
that can be compensated for by a counter pressure (e.g. CPAP, PEEP) indicates a 
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surfactant deficiency. In other words: every application of CPAP or PEEP with the 
intention to increase functional residual capacity (FRC), decrease intrapulmonary 
shunt and improve gas exchange, can only be interpreted as compensating for the 
increased retraction forces due to a damaged surfactant system. The degree of 
damage to this system is proportional to the application of CPAP or PEEP required. 
OVERVIEW OF EFFECTS OF ARTIFICIAL VENTILATION ON LUNG 
MECHANICS AND SURFACTANT FUNCTION 
Soon after the introduction of artificial ventilation in medical routine, side-effects of 
this therapy became obvious which led to extensive research in this area. Different 
ventilator modes were developed in an attempt to diminish these side-effects. 
Numerous clinical and experimental studies were performed to investigate e.g. the 
influence of PEEP, tidal volumes, frequency, inspiration/expiration ratios, inflations 
etc. during ventilation. 
Table 1 Summary of studies investigating surfactant fuctions in combination with artificiaf ventilation; 
conventional mechanical ventilation (CMV); high frequency ventilation (HFV). 
CMV 
Investigated Reference Conclusions 
parameters 
Tidal volume, 15-36 Artificial ventilation can decrease lung compliance, total !ung 
volume and surface activity of lung extracts. Normoventi!ation does 
not have a great influence on lung compliance etc, whereas 
hyperventilation {large tidal volumes) caused great changes to the 
ventilated lungs (abnormal X-rays and grossly abnormal lungs 
[30]). The changes induced by these changes are directly related 
to the size of the tidal volume used. Whenever large tidal volumes 
and for high peak inspiratory pressures are used microvascular 
damage due to volume overdistension can develop, leading to 
high permeability oedema, epithelial damage and hyaline 
membranes [27]. 
frequency, inspiratory 
pressure 
- 31 -
Investigated 
parameters 
End·expiratory 
pressure 
Duration 
inspiration; 
expiration ratio 
Inflation/sigh 
HFV 
Reference Conclusions 
17, 22, 24, The end·expiratory pressure used during ventilation is of great 
25, 34, 37· importance because the use of PEEP can prevent a decrease in 
47 lung compliance, total lung volume surface activity of lung 
16, 19 
48-56 
21, 22, 39, 
57-59 
70-92 
extracts. These beneficial effects of PEEP are directly related to the 
level of PEEP used. The mechanism by which PEEP prevents 
ventilator induced changes could be that PEEP prevents alveolar 
collapse and keeps the end·expiratory volume of the alveoli above 
a critical level of the static state of the surfactant film. PEEP should 
be cautiously applied because PEEP always results in cardio· 
vascular depression and can sometimes result in extravascular 
fluid retention in the lung. 
The longer a non·optimal ventilator setting is used, the greater the 
change in lung compliance etc, wili be. 
Pressure.controlled inversed ratio ventilation (IRV) which covered 
80 % of the ventilator cycle when compared to volume--controlled 
IRV showed reduced recoil pressure, improved blood gases and 
caused less morphological damage to surfactant deficient lungs. 
An occasional sigh or inflation during artificial ventilation can 
restore the decreased lung compliance (due to the ventilation) to 
normal. This effect can in part be attributed to a release of 
surfactant in the alveoli (strctch·effect}. Inflations with high 
pressures or large volumes can, however, induce alterations in 
solute·permeability of the alveo!ar·capillary barrier, eventually 
resulting in protein influx into the alveoli. This could reduce 
surfactant activity. Some authors state that sighs or inflations are 
not necessary in patients ventilated with large tidal volumes. In 
lungs with established disease, sighs/inflations did not seem to 
have great influence on gas exchange and compliance. 
Most studies showed no large difference in effects between 
conventional ventilation and HFV on gas exchange at the same 
mean airway pressures. In some studies, however, oxygenation 
was better with HFV than with CMV. This difference could be due 
to the fact that HFV maintains larger mean lung volumes due to 
gas trapping and auto·PEEP. The risk of barotrauma during HFV is 
decreased due to the smaller vo!umejpressure changes during the 
ventilation cycle with HFV when compared to CMV with large tidal 
volumes [76, 84}. Thus always preventing huge loss of surfactant 
during ventilation. 
All these studies employed various investigative methods including, for example, lung 
mechanics, blood gases, biochemistry, morphology, surface tension measurements 
of lung extracts, and epidemiology to characterise the effects of artificial ventilation 
on surfactant and lung mechanics. These studies are summarised in the table and 
some general conclusions concerning the effects of the different parameters are 
presented. 
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HOW ARTIFICIAL VENTILATION AFFECTS THE SURFACTANT SYSTEM 
Lung compliance, FRC and total lung volume are decreased in respiratory failure and 
can also decrease during anesthesia when artificial ventilation is applied to the 
patient. This is due to the formation of atelectatic areas in the ventilated lung. To 
prevent these changes from occurring, ventilator settings with large tidal volumes and 
high peak inspiratory pressures are used. Studies have shown, however, that these 
ventilator modes with large tidal volumes and high peak inspiratory pressures during 
artificial ventilation affect the pulmonary surfactant system [24, 29, 32, 43]. Moreover, 
these changes are directly related to the tidal volume used and the duration of the 
mechanical ventilation [see Table]. The exact mechanism by which the surfactant 
system is affected by artificial ventilation is not yet entirely clear. One factor is that 
the surfactant in the alveolar lining is actively removed from the alveolus towards the 
larger airways; this can lead to a shortage of surfactant at the alveolar level causing 
changes in surface tension characteristics in the lung, seen during or after prolonged 
periods of mechanical ventilation. 
In normal spontaneous breathing, during end-expiration the surfactant molecules 
covering the alveolar epithelium are compressed on the small alveolar area (leading 
to low surface tension or a high surface pressure) thus preventing the alveoli from 
collapse. II the surface of the alveolus is smaller than the surface occupied by the 
surfactant molecules, the molecules are squeezed out of the surface and forced 
towards the airways. These surfactant molecules are then 'lost' forthe alveoli and are 
eventually cleared from the lungs. During the following inflation of the alveoli, the 
surface is replenished with surfactant molecules coming from the underlying 
hypophase where surfactant molecules in micelles are 'stored' for later use. During 
the next expiration, the mechanism repeats itself and again surfactant molecules are 
forced out of the alveolus and subsequently replenished from the hypo phase; this is 
a continuing cycle (Figs. 1 and 2). 
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Fig. 1 Balance between synthesis, release and consumption of surfactant in the healthy lung. The 
pressure values given represent the intrapulmonary pressure needed to open up this a~veolus. 
At the surface and in the hypophase (micelles), there are sufficient molecul~s of surfae'"..ant. 
These micelles deliver the surfactant necessary to replace the molecules squeezed out dur:ng 
expiration. 
The amount of surfactant that must be produced and subsequently secreted by the 
alveolar type II cells is proportional to the loss of surface active molecules during the 
breathing cycle. When production and secretion of new surfactant molecules keep 
pace with consumption, no surfactant deficiency can occur, as in a normal healthy 
lung. 
It becomes clear that the rate of loss of surfactant is greater when the phasic volume 
changes of the alveolus are larger during the breathing cycle. When the alveoli are 
collapsed, for instance in atelectatic lung areas, the surfactant molecules are highly 
compressed on the surface and a significant part is forced out of the alveolus. The 
smaller the airspace, the lower the surface tension must be to retain airspace stability . 
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If the collapsed alveolus is subsequently highly inflated, replenishment from the 
hypophase must accordingly be larger than normal; even more so when a combin-
ation of high peak inspiratory pressures and large tidal volumes are used to open up 
collapsed airspaces. In these situations consumption is greater than normal and 
production and secretion of surfactant must increase to prevent a surfactant-deficient 
state. 
Rhythmic compression (expiration) and decompression (inspiration) of the alveolar 
lining during the breathing cycle thus causes loss of surfactant during artificial 
ventilation, especially when compression is far below the static state of the surfactant 
layer, which is normally equal to or just above the normal FRC level. The use of 
negative end-expiratory pressure (NEEP) or ventilation of a lung with an open thorax, 
exacerbates this process and thereby increases the loss of surface active molecules 
[37, 47]. 
The application of PEEP during mechanical ventilation prevents a decrease in lung 
compliance and surface activity of lung extracts [For review: 93]. This can be 
explained by the fact that PEEP prevents alveolar collapse and thus keeps the end-
expiratory volume of the alveoli above a critical level of the static state of the 
surfactant film, thereby preventing excessive loss of surfactant during expiration. 
It is established that during normal spontaneous breathing humans do occasionally 
sigh. Therefore, it was suggested that the addition of large inflations or sighs during 
mechanical ventilation could prevent the formation of atelectasis and subsequent 
decrease of lung compliance [21, 64]. Studies have shown that these periodic 
hyperinflations during mechanical ventilation are able to reopen collapsed airways 
and alveoli in normal healthy lungs [see Table]. Findings by Bendixen and Laver 
showed that a decrease of lung compliance can be reversed by a single large 
hyperinflation [94]. This reversal can, in part, be due to the fact that after 
hyperinflation the lamellar bodies (surfactant store) of type II cells are decreased in 
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volume and density (stretch-effect) which indicates extra release of surfactant by type 
II cells [59j. 
Fig. 2 
(a) Inspiration End-inspiration 
(b) Exp_ Insp_ 
5 CM HzO 
A: Imbalance between synthesis, release and consumption of surfactant due to artificial 
ventilation. At the beginning of inspiration, there exists an apparent deficiency of surfactant 
molecules but there is a respreading of molecules stored in ~he hypo phase to the surfactant 
layer. At the end of inspiration there is, in principle, enough surfactant on the surface. 
B: With the next expiration, surface active molecules are further squeezed out and no surface 
active molecules are left in the hypophase for respreading, creating the situation where a 
serious surfactant deficiency follows. 
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Another factor that might be of importance for deterioration of lung mechanics during 
ventilation is that mechanical ventilation, especially in non-homogenous lungs, creates 
severe shear forces between open and closed airways and possible overstretch of 
the epithelium during the breathing cycle, resulting in necrosis and desquamation of 
bronchiolar and alveolar epithelium [95, 96, 97]. Overstretch of the intercellular 
junctions of the epithelium leads to increased permeability with a resulting influx of 
various kinds of plasma proteins, like albumin and fibrinogen etc, which are known 
to inhibit surfactant function [98]. Impaired surfactant function will lead to decreased 
lung distensibility and collapse of alveoli and small airways leading to atelectasis, 
enlargement of the right-to-left shunt due to perfusion of non-ventilated alveoli, 
hypoxemia and acidosis [99, 100, 101]. Furthermore, the surfactant system itself is 
essential for stabilization of the fluid balance in the lung and for prevention of 
pulmonary oedema [1 02, 103, 104, 1 05]. Inhibition of the surfactant function by 
oedema constituents therefore accelerates the formation of pulmonary oedema and 
the development of respiratory failure resulting in a vicious circle of surfactant 
inactivation and loss of pulmonary function. The ventilator mode which is then 
necessary to ventilate these lungs is potentially more damaging than the ventilator 
settings that caused it. 
Summary of studies investigating the different aspects and parameters of ventilation 
on lung mechanics provides the rationale for optimal ventilator settings. These 
optimal ventilator modes should open up the whole lungs and should keep them 
totally open during the ventilatory cycle. All ventilator settings which keep the alveoli 
inflated during end-expiration, and thus above the critical level of the static state of 
the surfactant film, would prevent the non-physiologic consumption rate of surfactant 
due to artificial ventilation. Further, in the totally open lung there are no, or minimal, 
shear forces during ventilation which could damage the epithelium and indirectly 
damage the surfactant system as described above. A ventilator mode which fulfills 
these prerequisites is, for example, pressure controlled inversed ratio ventilation (IRV). 
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CONCLUSION 
Although artificial ventilation remains one of the major breakthroughs in modern 
health care it is clear that it should be applied cautiously. From the reviewed studies, 
which are largely different as to intention and methods used, the same conclusion 
can be drawn, namely: that when lungs are ventilated with large volumes and 
pressure changes the pulmonary surfactant system becomes depleted or in some 
other way damaged. This results in decreased pulmonary compliance which in turn 
creates the condition in which secondary lung oedema can develop. This leads to 
further damage and inactivation of the alveolar surfactant system. The ventilator mode 
which is then necessary to ventilate these lungs is potentially more damaging than 
the ventilator setting that caused it. In a diseased lung these pathophysiologic 
changes are probably more pronounced and severe than in healthy ventilated lungs. 
The results of these studies provide the rationale lor optimal ventilator settings 
(aiming at adequate gas exchange and minimal cardiocirculatory interference) which 
should produce smaller pressure-volume swings during the ventilatory cycle and keep 
the lung volume equal to or just above FRC level, to prevent a significant depletion 
of surface active material. One may also speculate that ventilator-induced changes 
in lung mechanics may be prevented by instillation of exogeneous surfactant. 
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EFFECTS OF HIGH FREQUENCY JET VENTilATION ON THE PULMONARY 
CLEARANCE OF ''mTc-DTPA IN RESPIRATORY FAILURE IN RABBITS 
SUMMARY 
The effects of high frequency jet ventilation (HFJV) at 2 and 15Hz on the pulmonary 
clearance of technetium 99m diethylene triamine pentaacetate ('9mTc-DTPA) were 
compared with conventional volume-controlled (VC) ventilation with positive end-
expiratory pressure (PEEP), in a model of respiratory failure induced by two lung 
lavages in adult rabbits. In group 1 the lungs were ventilated with HFJV at 2 Hz, and 
in group 2 ventilation was with HFJV at 15Hz; group 3 underwent VC conventional 
ventilation. Group 4 also had conventional ventilation, but without previous lung 
lavage and functioned as a control group. In all groups, mean airway pressure was 
maintained at a value to ensure Pa02 > 25 kPa. The measured half-life time (Ph) of 
the 99mTc-DTPA (mean (SD)) was: group 1, 28 (7.8) min; group 2, 73.5 (7.9) min; 
group 3, 56.5 (12.4) min and group 4, 92.6 (13.2) min. Assuming that conventional 
VC with PEEP ventilation causes no additional harm to surfactant depleted lungs, it 
is concluded that HFJV at 2 Hz leads to further damage of the lungs, whereas HFJV 
at15 Hz improves reparative processes, by keeping the lungs constantly inflated. 
INTRODUCTION 
High frequency jet ventilation (HFJV) is known to deliver continuous positive airway 
pressure (CPAP) and opens atelectatic lung units. Adequate oxygenation and 
elimination of carbon dioxide may be maintained with tidal volumes less than the 
anatomical dead space in animals and patients with respiratory failure [1, 2]. There 
is evidence that damage to the alveolar-capillary membrane is a consequence of 
large intra-pulmonary pressure-volume excursions [3]. Especially repeated closing 
and reopening of the alveoli may lead to damage of the alveolar-capillary membrane 
because of high shear forces [4, 5]. It is assumed that HFJV reduces pulmonary 
damage by keeping the lung inflated and avoiding shear forces. The amplitudes of 
the pressure excursions during HFJV are known to be inversely related to the 
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frequency used. It is possible, therefore, that HFJV at low frequency may lead to 
more lung damage than HFJV at high frequency. 
A sensitive index of the integrity of the alveolar-capillary barrier is the pulmonary 
clearance of inhaled 99"'technetium-diethylene triamine pentaacetic acid (""mTc-DTPA) 
[6]. The purpose of this study was to assess the effect of HFJV on this clearance rate 
in a model of respiratory failure induced by depletion of surfactant. The pulmonary 
clearance of 99~c-DTPA was measured, therefore, in surfactant depleted rabbits 
during conventional mechanical ventilation and during HFJV at two different 
frequencies. Structural abnormalities of the lung were examined histologically. 
MATERIALS AND METHODS 
The experiments were performed in 24 adult rabbits (2.5-3.5 kg body weight) 
allocated to four groups. The animals were anaesthetised with pentobarbitone 50-60 
mg kg·'. Tracheotomy was performed and a tube for applying high frequency 
ventilation (Hi-Lo jet, Mallinkrodt, U.S.A.) was inserted into the trachea. A carotid 
artery was cannulated for continuous monitoring of arterial pressure and blood 
sampling. Neuromuscular block was induced with pancuronium 0.3-0.4 mg kg·' i.m. 
All animals underwent ventilation with a Servo Ventilator 900 C (Siemens-Eiema AB, 
Sweden). Initially, the ventilation frequency (f) was 30 b.p.m, The inspiratory; 
expiratory (I:E) ratio was 1:2, Fi02 was 1.0 and minute ventilation was set to maintain 
PaC02 at 4-5 kPa. 
Respiratory failure was induced in 17 animals by performing lung lavage [7, 8]. In 
brief, lung lavage was performed with volumes of isotonic saline at 37 "C equal to 
the gas volumes needed to inflate the healthy lungs to 40 em H20. Each volume of 
saline was administered in two instillations through the tube at a pressure not 
exceeding 40 em H20 [7]. Two such lavages were performed. Alter induction of 
respiratory failure, the animals were allocated to three groups with different patterns 
of ventilation. In all three groups, the mean airway pressure (MAP) was adjusted so 
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that Pa02 would exceed 25 kPa. 
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Fig. 1 Schematic representation of the experimental apparatus. VU = valve unit; AP = arterial 
pressure; CU = control unit. 
In group 1 (n = 7) ventilation comprised HFJV at 2 Hz and in group 2 (n = 5) it was 
HFJV at 15Hz. The duty cycle was 20% in both groups. HFJV was applied by a high 
frequency jet ventilator (Servo HFV 970, Siemens-Eiema AB, Sweden) via the high 
frequency channel of the tube, whereas the main lumen was open. Group 3 (n = 5) 
underwent ventilation with conventional volume controlled (VC) ventilation (tidal 
volume 20 ml kg·', I:E ratio 1:2 and f 30 b. p.m.) with a positive end-expiratory 
pressure (PEEP) of 0.3-0.4 kPa. A control group of animals (group 4, n = 7) 
underwent ventilation with VC PEEP ventilation without surfactant depletion. 
The patterns of ventilation were applied for 60 min. A solution of 99"'Tc-DTPA was 
nebulized into the inspiratory line of the ventilator using an air jet nebulizer (Uitravent, 
Mallinkrodt Medical, The Netherlands). This type of nebulizer produces an aerosol 
with fine particles (0.6-2!-'m), favouring alveolar deposition. The supply of pressurized 
air to the nebulizer was controlled by a pneumatic valve which was connected to the 
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Servo Ventilator via an electronic circuit. The nebulizer operated only during 
expiration, filling the inspiratory line with aerosol in order to administer the particles 
with the ensuing insufflation. Any particles not retained in the lungs of the animal 
were trapped in a filter placed in the expiratory line of the ventilation circuit (fig. 1). 
Before each run of the nebulizer, the system was checked carefully for air leaks. The 
nebulizer and the filter were protected with heavy lead shielding. During nebulizing, 
in all groups pressure controlled ventilation was used with an insufllation pressure of 
2 kPa, an I:E ratio of 1:1 and a frequency of 100 b.p.m. in order to reach a high 
activity in a short time. When a count rate of approximately 200 counts per second 
(c.p.s.) over the lungs was reached (after 2-3 min), the aerosol administration was 
stopped, the experimental ventilation mode resumed and the clearance measurement 
started. Gamma camera images were obtained in successive 1-min frames for 20 min 
and stored in a 64 x 64 images matrix in a computer (Digital PDP 11 /34, Maynard, 
U.S.A.). The data from the clearance measurement were analysed by selecting a 
region of interest, which was both lungs in all animals, and generating a time-activity 
curve. A mono-exponential function was fitted to the experimental data and a half-life 
(TV..) of the tracer in the lungs calculated. 
When the clearance measurement was completed, the animal was killed with an 
overdose of pentobarbitone and the lungs were prepared for histological examination. 
Before fixation, the lungs were expanded with air for 5 min at a pressure of 2.94 kPa. 
This pressure was reduced to 0.98 kPa, which was maintained while the lungs were 
perfused for 60 min via the pulmonary artery with a solution of buffered 1% 
glutaraldehyde at a pressure of 6.37 kPa. The lungs were stored in 3.5% 
formaldehyde. Staining was with haematoxylin and afloxin. The sections were 
examined by light microscopy. 
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Statistical analysis 
All data are reported as mean (SD), unless stated otherwise. Differences between the 
means were tested by the Mann-Whitney-Wilcoxon test for unpaired samples. 
RESULTS 
The distribution of the inhaled ""'Tc-DTPA aerosol was uniform in the lungs of all 
animals. The TY.< of ""'Tc-DTPA in the lungs in the different groups of animals are 
shown in table I. The reference group had the longest T'h, 93 (13) min. In group 3, 
which was lavaged but had similar ventilation to the control group, the TY.< was 
reduced significantly, to 57 (12) min. The animals undergoing ventilation with HFJV 
at 2 Hz (group 1) had the shortest TY.< 28 (7.8) min, whereas group 2 (15 Hz) had the 
longest TY.< of the lavaged animals (73.5 (7.9) min), although this was not significantly 
greater than that of group 3. 
Table I Mean (SO) Pa02 and PaC02 , mean airway pressure {Pawp), mean arterial pressure (MAP) and 
half-life (Tlh) in the different groups. Significant differences (P<O.OS, Mann-Whitney-Wilcoxon 
test for unpaired samples): #groups 1 v. 3, 1 v. 4, 2 v. 4, 3 v. 4; +all groups comparisons; 
*groups 1 v. 2, 1 v. 3, 1 v. 4, 2 v. 4, 3 v. 4 
#Pa02 fPaC02 *Pawp MAP Tlh 
n (kPa) (kPa) (kPa) (kPa) (min) 
Group 1 
(2Hz) 7 28.16 2.12 1.4$ 13.56 28 
(18.04) (0.57) (0.39) (1.41) (7.8) 
Group 2 
(15 Hz) 5 38.64 6.90 0.81 14.88 73.5 
(13.07) (1.53) (0.1) (1.32) (7.9) 
Group 3 
(0.5 Hz) 5 55.73 4.50 0.79 14.07 57 
(6.57) (0.61) (0.1) (1.14) (12) 
Group 4 
(0.5 Hz. 7 70.20 4.20 0.38 14.90 93 
no lavage) (4.70) (0.6) (0.02) (1.47) (13) 
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Pa02 greater than 25 kPa could be maintained in the lavaged animals with all 
patterns of ventilation. Conventional VC PEEP ventilation (group 3) provided the best 
oxygenation and kept PaC02 within a normal range with the lowest mean airway 
pressure (P awp) (table 1). P awp was greatest in group 1; this was necessary to obtain 
a Pa02 greater than 25 kPa and led to hyperventilation (see PaC02). In group 2, 
however, the opposite results were found; for adequate oxygenation, alveolar 
ventilation was too small to maintain the PaC02 in the physiological range (table 1). 
Arterial pressure was stable at a normal value throughout the study in all groups. 
Under light microscopy, all lung samples from the lavaged animals showed evidence 
of pneumonitis, pulmonary oedema, bronchial and bronchiolar epithelial 
desquamation and necrosis as described previously [7]. The degree of pneumonitis, 
pulmonary oedema, bronchial and brcnchiolar epithelial damage varied between the 
three groups (figs 2-4). 
Fig. 2 Representative example of a rabbit in group 1. There is necrosis and desquamation of 
bronchiolar epithelium, pulmonary oedema and alveolar collapse. Haematoxylin and afloxin. 
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Fig.3 
Fig. 4 
Representative example of a rabbit in group 2. The lungs are well inflated. The alveoli are 
equally distributed. This is very similar to unlavaged lungs. Haematoxylin and afloxin. 
Representative example of a rabbit in group 3. The lungs are unequally ventilated with areas 
of good ventilation and areas of collapsed alveoli. The histological examination showed further 
damage to the alveolar epithelium which was, in degree, between the damage shown in the 
lungs of groups 1 and 2. Haematoxylin and afloxin. 
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In group 1, the lungs showed widespread atelectasis, alternating with areas of well-
expanded or even hyper-expanded alveoli. Necrosis and desquamation of airway 
epithelium were striking findings, especially in poorly expanded areas, combined 
usually with accumulation of oedema fluid in bronchioles and alveoli, and formation 
of hyaline membranes. The lungs showed minor foci of non-specific pneumonia. Also, 
small areas of interstitial and intra-alveolar haemorrhage were found. These 
histological results were confirmed by the measurements of the clearance rate of 
99
"'Tc-DTPA (table I) in this group. A typical example of this group is shown in figure 
5. 
The histological changes were less marked in group 3 and least obvious in group 2 
results which were also confirmed by the clearance rate measurements of 99"'Tc-
DTPA. Typical examples of these groups are shown in figures 6 and 7. In group 4 the 
epithelium was intact in all airways and no evidence of pneumonitis was found. 
DISCUSSION 
Surfactant depletion by lung lavage leads to increased alveolar surface tension and 
reduced lung compliance. The lavage procedure per se is not considered generally 
to cause substantial structural damage to the lung [8], but mechanical ventilation of 
the poorly compliant lung may cause severe structural damage [7]. The purpose of 
this study was to evaluate two modes of HFJV in the surfactant-depleted lung with 
respect to alveolar-capillary barrier integrity and structural changes. Conventional VC 
PEEP ventilation was included for comparison. 
The pulmonary clearance of 99"'Tc-DTPA reflects the transfer of the tracer from the 
alveoli to blood and hence the properties of the alveolar-capillary barrier. The rate of 
transfer of 99mTc-DTPA is often interpreted as representing the solute permeability of 
the alveolar epithelium [6, 9] but it has been suggested recently that it is also 
dependent on the functional integrity of the pulmonary surfactant system [1 0-13]. In 
normal humans and animals, the rate of pulmonary clearance of 99"'Tc-DTPA is 
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related to lung volume [14, 15]. The rate of clearance of 99"'Tc-DTPA increases if lung 
volume is increased by voluntary hyperinflation or application of PEEP. No 
information on lung volume was obtained in this study, but the MAP may be used to 
obtain an estimate of lung expansion, even if this is not accurate [16]. Increased rate 
of 99mTc-DTPA in the lavaged animals in this study may be caused by surfactant 
depletion per se, by derangement of the alveolar-capillary structure related to the 
effects of mechanical ventilation of the surfactant-depleted lung, or by differences in 
the patterns of ventilation. As the animals underwent ventilation lor 1 h after lavage, 
the effect of mechanical ventilation was not limited to causing lung injury, but also 
provided the possibility of restoration of lung function. 
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fig. 5 Clearance curve of ssmTc-DTPA of rabbit lungs shown in figure 2. The clearance half-life (Tlh) 
in this animal with severe lung damage was 10.5 min. 
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Fig. 6 
Fig. 7 
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Clearance cur.te of ssmTc-DTPA of rabbit lung shown in figure 3. The clearance half-life (Tlh) 
in this animal was 68.5 min. 
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The difference in pulmonary clearance of 99"'Tc-DTPA between groups 3 and 4 
illustrates the effects of surfactant depletion and possible structural lesions caused 
by VC mechanical ventilation [14]. HFJV at 2 Hz caused the fastest clearance of 
99mTc-DTPA which may indicate that this mode of ventilation caused more structural 
damage to the alveolar-capillary unit than conventional VC PEEP ventilation or HFJV 
at 15 Hz. This is confirmed by our histological data. As the MAP was highest in group 
1, increased lung volume may also have contributed to the increased rate of 99"'T c-
DTPA clearance. The animals undergoing ventilation with HFJV at 15 Hz (group 2) 
had the lowest rate of clearance of the lavaged animals, even though the difference 
from the conventional VC ventilation was not significant. The finding of a lower 
clearance rate in group 2 than in group 3 may indicate that HFJV at 15 Hz caused 
less structural damage to the lung or provided better conditions for restoration of 
lung morphology (or both) than conventional VC ventilation. 
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PULMONARY CLEARANCE OF ''mTc-DTPA AND EXPERIMENTALLY 
INCREASED ALVEOLAR SURFACTANT CONTENT IN RABBITS 
SUMMARY 
We measured clearance of ssmTc-DTPA in rabbits with experimentally increased 
alveolar surfactant content. In one group of animals, surfactant production was 
increased by treatment with ambroxol, another group was treated with tracheal 
instillation of natural surfactant. A group of untreated control animals and animals 
with instillation of saline was also studied. Clearance of ''mTc-DTPA was measured 
during standard conditions of mechanical ventilation and during ventilation with large 
tidal volumes. In ambroxol and surfactant treated groups, clearance rate was 
reduced compared to untreated control animals. In contrast, clearance rate 
increased after saline instillation. The differences were observed at both modes of 
ventilation. The findings indicate that the pulmonary surfactant system is a rate-
limiting factor for clearance of "mTc-DTPA and that the volume dependence of 
clearance is not explained by stretching of the alveolar wall only. 
INTRODUCTION 
The alveolar-capillary barrier allows free diffusion of gases but restricts the diffusion 
of water and solutes. The permeability of the alveolar-capillary barrier to small solutes 
can be studied by measurement ofthe pulmonary clearance of""'Technetium-labeled 
diethylene triamine pentaacetic acid (""'Tc-DTPA) [6, 13, 15, 27]. The radioactive 
tracer is administered as an aerosol and, subsequently, the radioactivity is measured 
over the lungs with a detector. A clearance curve is obtained, which reflects the 
transfer of the tracer across the alveolar-capillary barrier. 
99
"'Tc-DTPA is considered to be transported by simple diffusion via the paracellular 
route. Increased rate ol clearance in disease states is often interpreted to represent 
damage to the alveolar epithelium but, recently, the pulmonary surfactant system as 
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a rate-limiting factor lor the alveolar-capillary transfer of 99"'Tc-DTPA has gained 
increasing attention [5, 22, 24, 29]. The pulmonary clearance ol 99mTc-DTPA increases 
dramatically after surfactant depletion by lung lavage [11] and after administration of 
synthetic detergent, which interferes with surfactant function [9, 12, 14] 
The pulmonary clearance of inhaled 99"'Tc-DTPA is known to increase in response to 
increases in lung volume [1, 3, 10, 19, 21, 23, 25] e.g. by the application of positive 
end-expiratory pressure {PEEP) or by ventilation with large tidal volumes. 
The purpose of this study was to examine in a rabbit model, whether increased 
alveolar surfactant content affects the pulmonary clearance of 99"'Tc-DTPA under 
standard conditions of mechanical ventilation and during ventilation with large tidal 
volumes. 
MATERIAL AND METHODS 
We studied two models of increased alveolar surfactant content; stimulation of 
surfactant production by treatment with ambroxol and tracheal instillation of natural 
surfactant. New Zealand White adult rabbits {CPS, Zeist, The Netherlands) were used 
in this study. 
Experimental groups of animals: 
A group of eight animals with a mean body weight {BW) of 3.3 ± 0.6 kg (SO) served 
as untreated controls. 
A second group of eight rabbits with a mean BW of 3.2 ± 0.5 kg were injected 
intravenously with live doses (50 mgjkg per dose) of Ambroxol® (Mucosolvan, Dr 
Karl Thomae GmbH, Biberach an der Riss, FRG) with 12 h intervals, also prior to the 
clearance measurements. 
A third group of five rabbits with a mean BW of 2.6 ± 0.1 kg were treated with 
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instillation of natural surfactant. The surfactant used in this study is a natural 
surfactant isolated from bovine lungs in basically the same manner as previously 
described by Metcalfe et al [20]. Each animal was given 100 mg surfactant 
phospholipids/kg BW suspended in 5 ml of 0.6 % saline. The surfactant preparation 
was instilled into the tracheal cannula while the animal was breathing spontaneously. 
Three ml was instilled with the animal in the supine position. Three minutes later, the 
animal was placed in the prone position and another 2 nil was instilled. The animal 
continued to breathe spontaneously for another 3 min before being connected to the 
ventilator. 
A fourth group of lour animals with a mean body weight of 2.4 ± 0.2 kg were treated 
with tracheal instillation of 5 ml of saline, in the same manner as lor instillation of 
surfactant. 
Animal preparation and ventilation: 
The animals were anaesthetised with nembutal 50 mgjkg intravenously followed by 
additional doses as required to maintain anaesthesia. They were then tracheotomised 
and a neuromuscular block was induced with pancuronium bromide (0.3-0.4 mg kg·' 
i.m.). The animals were connected to a Servo Ventilator 900C (Siemens-Eiema AB, 
Solna, Sweden) and ventilated with pure oxygen. Ventilation was volume-controlled 
with an inspiratory time of 25% of the respiratory cycle. A ventilation frequency (f) of 
50 min·' was maintained during preparation and administration of the 99"'Tc-DTPA 
aerosol and for the first 20 min of the clearance measurement. The ventilation 
frequency was then changed to 20 min·', which was maintained for the following 20 
min of the clearance measurement. The end-tidal partial pressure for C02 (P ECO,) 
was monitored with a C02 analyser 930 (Siemens-Eiema AB) and inspiratory pressure 
was adjusted to keep P EC02 within a physiological range. A positive end-expiratory 
pressure (PEEP) of 2 em H,O was applied to prevent atelectasis. Peak and mean 
airway pressures as well as expired tidal volume were recorded from the pressure 
and flow transducers located in the Servo Ventilator. A carotid artery was cannulated 
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for blood pressure monitoring. 
Aerosol generation and administration: 
A solution of ""'Tc-DTPA was prepared from a commercial kit (fechnescan DTPA, 
Mallinckrodt Medical, Petten, The Netherlands) and put in an air jet nebulizer 
(Uitravent, Mallinckrodt Medical). The mass median diameter of the aerosol particles 
produced was 1. 7 I-'m as measured with a laser light scattering technique. The 
aerosol was administered via the ventilation circuit as described by Dahlback et al 
[4]. The nebulizer was placed in the inspiratory line of the ventilation circuit. Supply 
of pressurized air to the nebulizer was controlled by a pneumatic valve which, in turn, 
was connected to the SeNo Ventilator via an electronic circuit. During the period of 
aerosol administration, the nebulizer was operating during expiration only, filling the 
tubing in the inspiratory line with aerosol. The particles thus produced were 
administered with the ensuing insufflation. Aerosol was administered until a count rate 
of approximately 300 countsjs had been reached (alter 1-2 min). The clearance 
measurement was then immediately started. Gamma camera images were obtained 
in one-minute frames for 40 min and stored in a 64 x 64 image matrix in a computer. 
Experimental protocol: 
All animals quickly reached a stable condition alter the preparation as well as after 
the instillation of surfactant and saline. The 99"'T c-DTPA aerosol was administered with 
the initial mode of ventilation (ventilation frequency 50 min·'). The clearance 
measurement was then immediately started. The initial pattern of ventilation was 
maintained for the first 20 min of the clearance measurement. The ventilation 
frequency was then changed to 20 min·' and the inspiratory pressure increased with 
the intention of keeping P EC02 in the physiological range. This pattern of ventilation 
was maintained for the remaining 20 min of the clearance measurement. In one 
animal treated with surfactant instillation, clearance was measured during 20 min 
only. Airway pressures and tidal volume were recorded at each pattern of ventilation. 
When the clearance measurement was completed, the animal was killed with an 
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overdose of pentobarbital. 
Data analysis: 
We analysed the clearance measurements by selecting a region ol interest over both 
lungs and generating a time-activity curve (Fig. 1 ). Mono-exponential functions were 
then fitted to the experimental data from 1-20 min and from 21-40 min and the half-life 
(T!h) time ol the tracer in the lungs calculated. The correlation coefficient for the fit 
ranged from 0.92 to 0.99. 
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Fig. 1 Time-activity curve obtained over the lungs of a control animal. Count rate was expressed as 
a percentage of the initial value. A ventilation frequency of 50 min-1 was maintained for the 
first 20 min. The frequency was then changed to 20 min_, and the inspiratory pressure 
increased. Clearance rate increases in response to the change in ventilation pattern. 
Differences in P EC02 and T!h with respect to treatment and pattern of ventilation were 
analysed with analysis of variance using an additive model for the factors 
experimental group, animals within group and ventilation frequency. 
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RESULTS 
All animals could be kept under stable respiratory and circulatory conditions 
throughout the experiment. There was no significant difference in P EC02 between the 
experimental groups, but P EC02 was somewhat lower during ventilation with a 
frequency of 20 min·' than during ventilation with 50 min·' (p<0.05, Table 1). The tidal 
volume was about twice as high during ventilation with a frequency of 20 min·' than 
during ventilation with a frequency of 50 min·'. Tidal volume as well as airway 
pressures were slightly higher in the animals treated with surfactant or saline than in 
the other groups. 
Table 1 Ventilatory parameters registered during measurement of pufmonaryclearance of 99mTc-DTPA 
in ambroxol treated animals and in the control group. Values are means :t SEM. PEC02. end 
tidal partia! pressure for carbon dioxide; P peak• peak airway pressure; P mean· mean airway 
pressure; VT, tidal volume. 
PEC02 P peak Pmean VT 
(kPa) (em H20) (em H20) (mljkg) 
f=SO min-1 
Controls 4.2:!: 0.2 10.5 = 0.4 3.9 = 0.1 9.0 = 0.6 
Ambroxo! 4.0 = 0.1 10.0 = 0.4 4.0 = 0.1 8.5 = 0.3 
Surfactant 5.0 = 0.5 13.8 = 1.0 4.2 = 0.2 1, '1 = 0.8 
Saline 3.8 = 0.1 13.2 = 1.1 4.3 = 0.3 14.8 = 1.0 
f=20 min·1 
Controls 3.8 = 0.2 14.3 :! 0.4 5.3 = 0.1 20.9 = 1.4 
Ambroxol 3.7 = 0.1 14.9 = 0.8 5.3:!: 0.1 20.3 = 1.0 
Surfactant 4.2 = 0.4 17.6:!: 0.6 6.1 = 0.1 24.6 = 0.5 
Sarine 4.0 :!: 0.2 15.8:!: 1.1 6.0 = 0.2 24.5 = 0.4 
The mean (± SEM) T:h for the pulmonary clearance ol 99mTc-DTPA in the control 
group was 90 ± 5 min at f~50 min·' and fell to 69 ± 7 at f~2o min·' (Fig. 2). The T:h 
was longer in the ambroxol treated animals at both ventilation frequencies, mean 
values being 132 ± 9 and 1 02 ± 9 min. The results were similar in the animals 
treated with surfactant instillation, the T:h being 134 ± 13 min at f~so min'' and 125 
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± 15 at f=20 min·'. In the animals treated with saline instillation, however, the T'h was 
shorter than in the controls at both ventilation frequencies; 61 ± 4 min at 1=50 min·' 
and 56 ± 4 min atf=20 min·'. The analysis of variance showed significant differences 
between experimental groups (p<0.001) as well as between modes of ventilation 
(p<0.001). 
200 Control Ambroxol Surfactant Saline 
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Fig. 2 Half-life of 99mTc-DTPA in the lungs in the different experimental groups at the two modes of 
ventilation. Closed symbols indicate individual animals and horizontal lines mean values. 
DISCUSSION 
We have shown that ambroxol treatment and surfactant instillation reduce the rate of 
pulmonary clearance of 99mTc-DTPA in normal rabbits. The reduced clearance rate 
is observed both under standard conditions of mechanical ventilation and during 
ventilation with large tidal volumes. 
Ambroxol is known to increase the incorporation of palmitate into the phospholipid 
fraction of lung homogenates and of alveolar lavage fiuid in rabbits and rats [7, 8, 
28]. The amount of phospholipids recovered from the alveoli by lavage is also 
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increased in ambroxol treated rabbits and guinea pigs [16, 26]. In guinea pigs treated 
with the same dose of ambroxol as used in this study, the yield of phospholipids was 
increased by 60% [16]. Tracheal instillation of natural surfactant is known to increase 
alveolar phospholipid content and is frequently used in the treatment of idiopathic 
respiratory distress syndrome in newborns and also in a few cases of adult 
respiratory distress syndrome (ARDS) [17]. Both models used in this study thus 
represent experimentally induced states of increased alveolar surfactant content. 
The rate of pulmonary clearance ol 99mTc-DTPA increases with lung volume, and the 
conditions of mechanical ventilation therefore need to be carefully controlled. In this 
study, there were only trivial differences between experimental groups in the 
insufflation pressures used and the tidal volumes recorded. Increased alveolar 
surfactant content may affect lung compliance, i.e. the relation between distending 
pressure and volume. A previous study has shown that ambroxol in the dose used 
in this study does not affect lung mechanics in guinea pigs [16]. There is no 
indication in this study of any substantial difference in compliance of the respiratory 
system between the three groups of animals. Furthermore, the most likely effect of 
a moderate increase in alveolar surfactant content would be an increase in lung 
compliance, which would tend to increase lung volume at a given distending 
pressure. The reduction in the rate of pulmonary clearance of 99"'Tc-DTPA in the 
experimental groups relative to the control group is not likely to be explained by 
differences in lung volume. 
The rate limiting factors for the diffusion of 99mTc-DTPA across the alveolar-capillary 
barrier are incompletely understood. The pulmonary surfactant system has been 
proposed as one rate limiting factor. This suggestion has largely been based on 
experimental derangement of surfactant function. Evander et al. [11] showed that the 
pulmonary clearance of ssmTc-DTPA increased after surfactant depletion by lung 
lavage, and that this effect was partly reversed by surfactant replacement after 
lavage. Evander et al. [9] and Jefferies et al. [14] used the synthetic detergent dioctyl 
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sodium sulfosuccinate to disturb surfactant function and found that the pulmonary 
clearance of 99"'Tc-DTPA increased dramatically. Subsequently, Evander et al. [12] 
also demonstrated a relation between the dose of synthetic detergent administered 
and the effect on clearance. The present finding of reduced rate of pulmonary 
clearance of 99"'Tc-DTPA in two experimental models of increased alveolar surfactant 
content provides further evidence that the pulmonary surfactant system is a rate 
limiting factor for the alveolar-capillary transfer of 99"'T c-DTPA. Although the two 
models of increased alveolar surfactant content are different, the changes observed 
in pulmonary clearance of 99"'Tc-DTPA are remarkably similar. 
Effros [5] has reviewed several mechanisms whereby surfactant could influence the 
pulmonary clearance of 99"'Tc-DTPA. Surfactant could affect the spreading of the 
tracer in the epithelial lining fluid. If permeability varies within the alveolus, e.g. is 
greater in the corners, this would affect the clearance rate. If excess alveolar 
surfactant increases the thickness of the epithelial lining fluid, this would reduce 
clearance rate. Tubular surfactant may obstruct interepithelial diffusion pathways and, 
finally, 99"'Tc-DTPA may bind to some component of surfactant. 
It is well established that pulmonary clearance of 99"'Tc-DTPA increases with lung 
volume [1, 3, 10, 19, 21, 23, 25]. The mechanism is generally considered to be 
stretching of the alveolar epithelium with widening of intercellular junctions [1, 3, 19, 
21, 25]. Increased alveolar volume has been suggested to reduce the thickness of 
the alveolar lining fluid and thereby increase clearance rate [5]. Ventilation with large 
tidal volume has, however, also been suggested to affect the surfactant system, 
probably by greater loss of surfactant into the airways [2, 10]. We found the 
clearance rate to be lower in the two experimental groups than in the control group 
at both modes of ventilation. The clearance rate was somewhat slower during 
ventilation with large tidal volumes in the treated groups than during ventilation with 
small tidal volumes in the control group. Assuming similar compliance of the 
respiratory system, the time weighted average of lung volume should be higher 
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during ventilation with large tidal volume than during ventilation with small tidal 
volume. The findings in this study therefore indicate that simple stretching of the 
alveolar wall is unlikely to be the only mechanism for increased pulmonary clearance 
of 99"'Tc-DTPA during ventilation with large tidal volumes. 
We found the relative change in clearance rate in response to the change in 
ventilation pattern to be similar in ambroxol treated animals as in controls and only 
slightly lower in animals treated with surfactant instillation. If pulmonary surfactant 
were the dominating limiting factor for alveolar-capillary transfer of 99mTc-DTPA, the 
response to a change in ventilation pattern might be expected to be attenuated in the 
experimental groups of animals. It appears difficult to explain the volume dependence 
of the pulmonary clearance of 99mTc-DTPA on the basis of alveolar wall stretching, or 
effects on the pulmonary surfactant alone. 
In animals treated with saline instillation, the TY, was lower than in any other group. 
Lung lavage is a well established model for inducing surfactant dysfunction and 
respiratory distress [18]. The present findings suggest that surfactant function may 
be compromised by introduction of as little as 5 ml of saline into the airways. This is 
supported by the finding that pulmonary clearance of 99"'Tc-DTPA may increase 
dramatically without any change in dynamic compliance of the respiratory system or 
arterial oxygenation when surfactant dysfunction is induced by detergent 
administration [9]. 
In summary, this study has shown that the rate of pulmonary clearance of 99mTc-
DTPA is reduced in rabbits treated with ambroxol and in rabbits given natural 
surfactant relative to untreated controls. The difference applies to standard conditions 
of mechanical ventilation and to ventilation with large tidal volumes. The findings 
indicate that the pulmonary surfactant system is a rate limiting factor for the alveolar-
capillary transfer of 99mTc-DTPA. The study also indicates that the volume dependence 
of the pulmonary clearance of 99mTc-DTPA is not explained by stretching of the 
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alveolar wall only. 
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PUlMONARY ''mTc-DTPA ClEARANCE: A VERY EARlY INDEX FOR 
PERMEABiliTY CHANGES INTHEAlVEOlAR-CAPillARYBARRIER IN RABBITS 
SUMMARY 
A method for fast and accurate evaluation of the permeability of the alveolar-capillary 
membrane is by measurement of pulmonary clearance of radiolabeled hydrophylic 
solutes, such as Technetium-99m-diethylene triamine pentaacetate ("'mTc-DTPA). 
Using this technique we report a study in rabbits which recovered from a mild 
respiratory insufficiency after a period of 140 min of mechanical ventilation with 100% 
0 2 (group 1). Respiratory insufficiency in group 1 was induced by two lung lavages. 
As controls we used animals which were mechanically ventilated with the same 
settings as group 1 but not lavaged (group 2}, and animals which were neither 
ventilated nor lavaged (group 3). During mechanical ventilation for 140 min blood 
gas values of group 1 restored to normal compared to those of controls in groups 
2 and 3. Pulmonary clearance, however, was still abnormally high in group 1 
compared to the two other groups, indicating a greatly disturbed permeability of the 
alveolar-capillary barrier. It is concluded that pulmonary clearance of ''mTc-DTPA is 
a very sensitive technique for detection of any disturbance of the alveolar-capillary 
membrane. 
INTRODUCTION 
The adult respiratory distress syndrome (ARDS), as first described by Ashbaugh and 
colleagues more than 20 years ago [1 ], is a syndrome commonly found in intensive 
care units nowadays. Because of its complex pathogenesis and high mortality rate, 
it represents one of the major problems in modern intensive care medicine, both from 
the therapeutic and financial viewpoint. Although ARDS may have many different 
pathophysiological causes, the timely onset of treatment could be one of the most 
important factors influencing the final outcome [2]. The earlier therapeutical measures 
are taken, the better the prognosis for the patient. This means that early diagnosis 
of a possible developing ARDS is extremely important. 
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For normal function of the respiratory system, the integrity of the alveolar-capillary 
barrier is an important factor in that it normally allows rapid exchange of oxygen and 
carbon dioxide between the blood and alveolar air. It also restricts, however, the 
diffusion of large molecules, such as albumin and other blood proteins, from the lung 
capillaries into the alveoli. When the integrity of this barrier is altered, as in ARDS, 
permeability is increased allowing high permeability oedema to develop. This results 
not only in deterioration of blood gas tensions but also leads to inhibition of the 
pulmonary surfactant system by the presence of various plasma proteins [3, 4]. 
Surfactant is normally responsible for mechanical stabilisation of the alveoli and small 
airways during the ventilatory cycle and protects against formation of lung oedema 
[5, 6]. Thus an intact pulmonary surfactant system is vital for normal gas exchange. 
Being part of the alveolar-capillary barrier, it is obvious that functional integrity of the 
surfactant system also plays a role in maintaining normal permeability of this barrier. 
An indication of the permeability of the alveolar-capillary barrier may be of major 
diagnostic and, possibly, therapeutic importance. A method for fast and accurate 
evaluation of the permeability of the alveolar-capillary membrane is by measurement 
of pulmonary clearance of radio-labelled hydrophylic solutes. A much-used solute is 
""'Technetium-labelled-diethylene triamine pentaacetic acid ('""'Tc-DTPA) which 
allows non-invasive assessment of the integrity of the alveolar-capillary barrier [7, 8, 
9]. 
When one part of the alveolar-capillary barrier is damaged as, for example, by 
removing the alveolar surfactant lining by lung lavage, blood gas tensions are known 
to deteriorate [10]. The purpose of this study was to compare the sensitivity of 
pulmonary clearance of 99"'Tc-DTPA with that of blood gas analysis to characterise 
mild respiratory insufficiency in rabbits under conditions of mechanical ventilation. 
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MATERIALS AND METHODS 
Twenty-one New Zealand adult rabbits (CPB, Zeist, The Netherlands) (2.5 ± 0.5 kg 
body weight) were used. Permission was obtained from the institutional animal 
investigation committee. All animals were anaesthetised with pentobarbital (50-60 mg 
kg·' i.v.) with additional doses, as required, to maintain anaesthesia. Following 
tracheotomy a carotid artery was cannulated for arterial blood pressure monitoring 
and blood sampling. Neuromuscular block was induced with pancuronium (0.3-0.4 
mg kg·' i.m.). All animals were ventilated using a Servo Ventilator 900 C (Siemens 
Elema AB, Solna, Sweden) with, initially, the following ventilator settings: frequency 
(f) was 30 b.p.m, the inspiratory: expiratory (1/E) ratio was maintained at 1:2, Fi02 was 
1.0 and minute ventilation was set to maintain PaC02 between 30-40 mm Hg. 
Animals were divided into three groups (7 per group). In group 1, a very mild 
respiratory failure was induced by lung lavage according to Lachmann [10]. In brief, 
lavage was performed with 30 ml kg·' of isotonic saline at 37• C equal to the gas 
volume needed to inflate the healthy lungs to about 40 em H20. Each volume of 
saline was administered through the tube at a pressure not exceeding 40 em H20. 
Two such lavages were performed. After induction of respiratory failure, group 1 was 
volume controlled ventilated with the following ventilator settings: tidal volume (VT): 
10-12 ml kg·' and positive end-expiratory pressure (PEEP) of 3 em H20. Group 2, 
with no lavage, was also ventilated for 2 h with the same settings as group 1 and 
served as healthy controls. To investigate any possible deleterious effects of the 2 h 
period of mechanical ventilation on the integrity of the alveolar-capillary barrier a third 
group was not lavaged and not ventilated for 2 h, and clearance measurements 
began immediately after preparation of these animals (group 3). 
During the period of mechanical ventilation, blood gas tensions were measured (ABL-
330, Radiometer, Copenhagen, Denmark) at 15, 60 and 140 min. At 120 min 
clearance measurements of 99mTc-DTPA started. 
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Clearance Measurements 
A solution of ""'Tc-DTPA, prepared from a commercial kit (fechnescan DTPA, 
Mallinckrodt Medical, Petten, The Netherlands), was nebulized into the inspiratory line 
of the ventilator using an air jet nebulizer (Uitravent, Mallinckrodt Medical, The 
Netherlands). This type of nebulizer produces an aerosol with fine particles (mean 
size 1.7 ,.m, as measured by laser light scattering), favouring alveolar deposition 
[11]. The supply of pressurized air to the nebulizer was controlled by a pneumatic 
valve connected to the ventilator via an electronic circuit (for set-up see Fig. 1 ). 
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Fig. 1 Experimental set~up. ln contrast to the schematic, blood was drawn from the carotid artery. 
The nebulizer operated only during expiration, filling the inspiratory line of the 
ventilation circuit with particles; this in order to administer the particles with the 
ensuing insuffiation. Any particles not retained in the lungs ofthe animal were trapped 
in a lead-shielded filter placed in the expiratory line of the ventilation line [12]. 
Before each run of the nebulizer, the ventilatory system was checked carefully for air 
leaks. During aerosol administration, all groups were pressure controlled ventilated 
with an insufflation pressure of 20 em H20, an 1/E ratio of 1:1 and a frequency of 30 
b.p.m in order to reach a high activity over the lungs in a short time. When 
approximately 200-300 counts per second overthe lungs was reached (after 2-3 min), 
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aerosol administration was stopped, the initially used mechanical ventilation was 
resumed and clearance measurement started. Gamma camera images were obtained 
in successive 1-min frames for 20 min and stored in a 64x64 images matrix in a 
computer (Digital PDP 11/34, Maynard, USA). 
Data from the clearance measurements were analysed by selecting a region of 
interest, including both lungs of the animals, and generating a time-activity curve. A 
mono-exponential function was fitted to the experimental data and the half-life (T:h) 
of the tracer in the lungs calculated. When the clearance measurement was 
completed, animals were sacrificed by an i.v. overdose of pentobarbital. 
Statistical analysis 
Values are given as mean ± SO. Differences between the means were tested by the 
Mann-Whitney-Wilcoxon test for unpaired samples. P = <0.05 was considered to be 
statistically significant. 
RESULTS 
Table 1 P a02 and P 3C02 values in mm Hg. Significant differences (P<O.OS, Mann-Whitney-Wilcoxon 
test for unpaired samples): # group 1 versus groups 2 and 3. Values are mean = SD. 
Group 2 3 
Pa02 P3C02 Pa02 
Control 537 32.2 550 
::!:. 18 :!: 4.9 :: 13 :!: 6.3 :!: 16 = 5 
Time 
(min) 
15 379# 33.2 557 33.4 564 36 
= 148 :!: 6.5 :!: 20 = 5.2 :!: 13 = 4 
60 435# 34.1 576 38.4 
= 180 = 5.7 =34 = 3.4 
140 579 31.3 587 36.7 
::!:. 34 = 4.0 = 19 = 4.5 
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Surfactant depletion by two lung lavages in group 1 resulted in a mild respiratory 
insufficiency characterised by a statistically significant decrease in Pa02 (Table 1). 
During the course of the study period, blood gas values in these animals returned to 
normal and after 140 min there was no statistically significant difference between the 
three groups. 
However, permeability ofthe alveolar-capillary barrier, as assessed by clearance rates 
of ssmTc-DTPA in the groups, showed a statistically significant difference. The 
calculated T:h of ssmTc-DTPA was: group 1, 19 ± 4.7 min; group 2 (no lavage, but 
ventilated for 2 h) 93 ± 13 min; and group 3 (no lavage and not ventilated for 2 h) 
90 ± 15 min. The clearance curves of the three groups are-shown in Figure 2. Arterial 
blood pressure remained stable in all animals of all groups during the entire study. 
100 
80 
60 
40 
1 1 0 
TIME (MIN) 
Fig. 2 Time-activity curves (means) of 99mTc-DTPA in animal lungs. 
(dashed line: group 1; broken line: group 2; solid line: group 3) 
- 81 -
20 
DISCUSSION 
The measurement technique for pulmonary clearance of '"mTc-DTPA is a relatively 
new, easy to perform, non-invasive method for assessment of the permeability of the 
alveolar-capillary barrier. This barrier, consisting of several structural layers, plays a 
major role in gas exchange in that it enables optimal conditions for the process of 
oxygen and carbon dioxide transport. 
Although the technique has been well investigated over the last years, the 
mechanisms which influence or dictate the clearance rate of "~ c-DTPA are not yet 
fully understood [for review see 9]. Most theories focus only on the integrity of the 
alveolar epithelium as the main factor of influence for the diffusion rate across the 
alveolar-capillary barrier. The mechanism behind this theory is that the hydrophilic 
solute molecule must pass through the aqueous pores between the alveolar epithelial 
cells, the so-called intercellular junctions. These pores have a median diameter of 0.6-
1.0 nm. When compared to the median diameter of a 99~c-DTPA molecule(± 0.57 
nm) it is highly probable that the main route of diffusion of the tracer across the 
alveolar-capillary layer is through these pores. 
Studies by Evander and Wollmer, however, show that not only the alveolar epithelium 
dictates the diffusion rate but also the pulmonary surfactant system [13, 14]. In a 
rabbit model they demonstrated that after removal of the surfactant layer in the alveoli 
by lung lavage, the clearance rate of 99mTc-DTPA across the alveolar-capillary 
membrane increases greatly. That this increase in clearance rate could not be 
attributed to damage of the alveolar epithelium by lavage was demonstrated by the 
fact that surfactant replacement restored the pulmonary clearance rate of "mTc-DTPA 
to almost normal values. Another indicator of the importance of the surfactant system 
is the greatly increased pulmonary clearance rate in patients with ARDS and neonates 
with hyaline membrane disease [15, 16]. One established pathophysiological factor 
in both these syndromes is a significant surfactant deficiency with its concomitant 
results [17]. In experimental ARDS models, e.g., by infusion of intravenous oleic acid 
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or by prolonged ventilation with 100% oxygen resulting in oxygen toxicity, results also 
show an increased diffusion rate [18, 19]. The increased permeability of the alveolar-
capillary barrier, as measured by the 99mTc-DTPA clearance technique, is also seen 
in other acute lung diseases e.g. pneumocystis carinii pneumonia [20] 
In a study by Evander and coworkers to further investigate the possible rate-limiting 
influences of surfactant, a detergent (dioctyl sodium sulfosuccinate) was aerosolised 
and administered to the lungs of rabbits [21]. This detergent does not cause any 
structural damage to the alveolar epithelium, does not increase microvascular 
membrane permeability to macromolecules, and acts only on the surfactant system 
[22]. At 30 min after administration of the detergent, blood gas tensions and lung 
mechanics had not changed, but the clearance rate of "mrc-DTPA from the lungs 
had increased greatly. The authors conclude that this effect must be due to the fact 
that the detergent acts on the surfactant layer, interfering with both function and 
integrity. That blood gas tensions did not change significantly, indicates that the 
detergent's interference with the surfactant layer was minimal and this underlines the 
high sensitivity of the clearance technique for permeability assessment of the alveolar-
capillary barrier. 
These findings provided the rationale forth is investigation on the diagnostic sensitivity 
of 99mTc-DTPA clearance in a mild respiratory insufficiency. The pulmonary clearance 
measurements of 99mTc-DTPA in this study show that permeability of the alveolar-
capillary barrier of group 1 which was partly depleted from the alveolar surfactant is 
abnormally high compared to groups 2 and 3. This difference in clearance of the 
tracer molecule cannot be attributed to the 2 h period of mechanical ventilation 
because no differences in clearance measurements exist between groups 2 (no 
lavage but ventilated for 2h) and 3 (no lavage, not ventilated for 2h). Thus, the greatly 
increased permeability of the alveolar-capillary barrier in group 1 can only be 
attributed to the lung lavage procedure in this group. 
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The procedure of lung lavage induces mild respiratory insufficiency by surfactant 
depletion which may lead to minor atelectasis, followed by intrapulmonary shunting 
and intrapulmonary fluid accumulation with subsequent deterioration of blood gas 
tensions [6]. Damage to the surfactant system in the whole lung, however, was so 
mild that, with the applied ventilator settings, blood gases of group 1 were restored 
to normal after 140 min. Moreover, that after 2 h of mechanical ventilation the mild 
respiratory insufficiency was restored to normal at least suggests that the pulmonary 
surfactant system was also normalised. However, the finding that the pulmonary 
clearance of 99mTc-DTPA is still abnormally high indicates that the surfactant system 
in group 1 has not yet fully restored to normal. 
The proven sensitivity of pulmonary clearance measurement of 99~c-DTPA enables 
to use this technique for detection of a damaged and more permeable alveolar-
capillary barrier and, in particular, possible very early detection of a disturbed 
pulmonary surfactant system. Moreover, that alteration of therapeutic measures for 
lung diseases characterised by surfactant deficiency only on the basis of blood gas 
values can neglect the fact that normal blood gas values measured during 
mechanical ventilation (including PEEP) does not necessarily mean that the 
permeability of the alveolar-capillary barrier, and thus the integrity of the surfactant 
system, has also restored to normal. This finding indicates that additional care is 
needed in this area of lung diseases and that 99~c-DTPA clearance measurements 
could have a role in assessment of the permeability of the alveolar-capillary barrier. 
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PUlMONARY ClEARANCE OF "mTc-HUMAN SERUM ALBUMIN AND EFFECTS 
OF SURFACTANT REPlACEMENT AFTER LUNG lAVAGE 1111 RABBITS 
SUMMARY 
Pulmonary clearance of technetium-labelled human serum albumin ("'mTc-HSA) was 
measured in order to investigate whether the surfactant layer is a/so a rate-limiting 
factor when measuring the permeability of the alveolar-capillary membrane using 
99mTc-labelled albumin. Three groups of rabbits were studied: group 1 received 
natural surfactant after lung lavage; group 2 underwent lung lavage only, whereas 
group 3 served as untreated, healthy controls. All animals of group 2 had bi-
exponential clearance curves of the tracer, the half-life (T'h) of the fast and slow 
compartments being 14.6 ± 6. 7 min and 459.8 ± 167 min, respectively. In group 1, 
all animals except one a/so had bi-exponential clearance curves; T'h of the fast 
compartment being 35.9 ± 6.4 min and T'h of the slow compartment, 847.5 ± 143.5 
min. The animals of group 3 had mono-exponential clearance curves with T'h of 618 
± 241 min; after applying high airway pressure ventilation, T'h decreased to 236 ± 
121 min. These results indicate that the surfactant layer is a/so for 99mTc-HSA 
clearance measurements a rate-limiting factor. It is a/so concluded that the use of 
99mTc-HSA does not provide many advantages above the use of 99mTc-DTPA as tracer 
molecule. 
INTRODUCTION 
Techniques using radio-labelled solutes for permeability measurements of the 
alveolar-capillary membrane have been a subject of extensive research over the last 
decade. Introduced by Rinderknecht and others [Rinderknecht et al, 1977; Huchon 
et al, 1981], most workers administer the tracer molecule directly to the lung and 
monitorthe clearance rate of the tracer molecule from the lungs. The most commonly 
used tracer istechnetium-99m-labelled diethylene triamine pentaacetate ("9~ c-DTPA). 
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This hydrophillic solute (molecular weight 492, radius ± 0.6 nm) is thought to diffuse 
through the intercellular junctions between the alveolar epithelium. Although several 
factors are known to influence the clearance rate of 99"'Tc-DTPA across the alveolar-
capillary barrier, the integrity of the pulmonary surfactant system seems to be one of 
the most important rate-limiting determinants [Evander et al, 1987, 1988]. Pulmonary 
clearance of 99"'Tc-DTPA has been shown to increase after inducing surfactant 
deficiency by lung lavage or hydrochloric instillation and to decrease after 
experimentally increasing alveolar surfactant content [Evander et al, 1987; Jefferies 
et al, 1984a; Bas et al, 1991 a]. Clinical indications for the importance of the surfactant 
system for 99"'Tc-DTPA clearance rate have been shown in studies in humans: 
increased clearance rates of 99mTc-DTPA were observed in disease states where 
surfactant deficiency is a pathophysiological factor as, for instance, in hyaline 
membrane disease and the adult respiratory distress syndrome (ARDS) [Braude et 
al, 1986; Jefferies et al, 1984]. 
Pulmonary clearance rate measurements of 99mTc-DTPA have proven to be a very 
sensitive method for detecting alterations in the alveolar-capillary membrane whilst 
other more standard methods, such as blood gas tension measurements and lung 
mechanics, did not reflect any changes [Evander et al, 1988]. Some workers, 
however, have queried the sensitivity of the technique based on the fact that, even 
in healthy lungs, pulmonary clearance of 99"'Tc-DTPA can increase to levels found in 
severe ARDS by physiological factors, such as increase of lung volume, or even by 
cigarette smoking [Jones et al, 1980; Nolop et al, 1986; Cooper et al, 1987]. This led 
to the hypothesis that 99mTc-DTPA is a too small molecule to 1) allow discrimination 
between intermediate damage and severe damage to the membrane and 2) to allow 
discrimination between increase in permeability resulting from damage to the 
membrane and increase due to physiological factors. This provided the rationale for 
using radio-labelied solutes which have a greater molecular weight and radius as, for 
instance, human serum albumin (''mTc-HSA) (± 69,000 dalton, 3.5 nm [Egan et al, 
1983]) so that influence on clearance from physiological factors, like lung volume, 
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would be largely eliminated. 
The purpose of this study was to investigate whether the alveolar surfactant layer is 
also a rate-limiting factor in the pulmonary clearance of ssmTc-HSA and whether 
subsequent exogenous surfactant instillation after lung lavage would restore the rate 
of clearance to almost normal values, as is achieved with 99mTc-DTPA clearance rates. 
MATERIALS AND METHODS 
Twenty New Zealand adult rabbits (CPB, Zeist, The Netherlands) (2.5 ± 0.5 kg 
bodyweight) were used. Approval of the protocol was obtained from the institutional 
Animal Investigation Committee. The animals were anaesthetised with nembutal 50 
mg kg·' intravenously. Following tracheotomy, neuromuscular blockage was induced 
with pancuronium bromide 0.3-0.4 mg kg·' i.m. A carotid artery was cannulated for 
blood gas measurements and blood pressure monitoring (Fig. 1 ). 
Initially, all animals underwent pressure controlled ventilation using a Servo Ventilator 
900 C (Siemens-Eiema AB, Solna, Sweden). The ventilator settings were accordingly: 
frequency (f) of 30 min·', inspiratory/expiratory ratio of 1:2, Fi02 was 1.0 and a 
positive end-expiratory pressure (PEEP) of2 em H20 was applied in order to prevent 
atelectasis formation during preparation. The minute ventilation was set to keep 
PaC02 between 30 - 40 mm Hg. Peak, mean airway pressures and expired tidal 
volumes were recorded from the pressure and fiow transducers located in the 
Servo Ventilator 900 C. 
Respiratory failure was induced in 13 animals by performing lung lavage [Lachmann 
et al, 1982]. In brief, lung lavage was performed with 30 ml kg·' of isotonic saline at 
3JO C. Each volume of saline was administered through the tube at a pressure not 
exceeding 40 em H20. The lungs were ravaged until Pa02 fell below 100 mm Hg with 
the following ventilator settings: f was 30 min·', peak inspiratory airway pressure at 
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26 em H20, Fi02 ol1.0 and a PEEP of 6 em Hp. Animals were randomly assigned 
to group 1, 2 or 3. In group 1 (n=7) natural surfactant was instilled via the tracheal 
tube after the lavage procedure. Group 2 (n=6) received no surfactant. Another 
group of seven animals served as untreated, healthy controls (group 3). Group 3 was 
ventilated for 60 min according to the initial settings during preparation. After 60 min, 
the ventilator settings were changed to the same settings as in groups 1 and 2. This 
in order to exclude any possible effect of ventilation on clearance of the solute. 
The surfactant used in this experiment is a natural surfactant isolated from bovine 
lungs in basically the same manner as previously described by Metcalfe and 
colleagues [Metcalfe eta!, 1980]. Each animal was given 100 mg surfactant 
phospholipids kg., bw suspended in 0.6% saline (25 mg phospholipids ml"1 saline). 
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Fig. 1 Schematic representation of the experimental apparatus. 
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A solution of ''mTc-HSA was prepared using a commercial kit (T echnescan DRN 
4361, Mallinckrodt Diagnostica, Petten, The Netherlands) and placed into an air jet 
nebulizer (Uitravent, Mallinckrodt Diagnostica, Petten, The Netherlands). Before and 
after nebulizing, the binding percentage oft he 99mTc-label with the HSA-molecule was 
tested using thin layer chromatography. 
The aerosol was then administered via the ventilation circuit as earlier described by 
Dahiback [Dahl back et al, 1989]. In brief: the nebulizer was placed in the inspiratory 
line of the ventilation circuit. The supply of pressurized air to the nebulizer was 
controlled by a pneumatic valve which, in turn, was connected to the ServoVentilator 
via an electronic circuit. During the period of aerosol administration, the nebulizer was 
operating during expiration only, filling the tubing in the inspiratory line with aerosol. 
The particles thus produced were administered with the ensuing insufflation. Aerosol 
was administered until a count rate of approximately 300 counts/shad been reached 
(after 1-2 min). The clearance measurement was then immediately started. Gamma 
camera images were obtained in one-minute frames for 120 min and stored in a 64 
x 64 image matrix in a computer (Digital PDP 11/34, Maynard, U.S.A.). 
After 11 0 min, a small dose of 99mTc-HSA was injected intravenously in all animals in 
order to correct lor blood background activity as described by Barrowcliffe and 
colleagues [Barrowcliffe et al, 1988]. 
During the study period, blood gas tensions were measured at 0, 30, 60, 90 and 120 
min. When the clearance measurement was completed, the animal was killed with an 
overdose of nembutal. After the study period, lung fluid was collected (whenever 
possible) from the animals of groups 1 and 2 for total protein measurement. 
Data analysis: 
Clearance measurements were analysed by selecting a region of interest over both 
lungs and generating a time-activity curve (Fig. 2). Each corrected time-activity curve 
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was analysed by fitting a mono- (eq. 1) as well as a bi-exponential (eq. 2) equation 
to the experimental data. 
A(t) = A(O) e·ict (eq. 1) 
(eq. 2) 
A(t) is the radioactivity in the lung at any time t, A(O) the radioactivity in the lung at 
time zero and k the decay constant. In the bi-exponential analysis, AF(O) and A8 (0) 
represent the amount of radioactivity eliminated with the fast (kF) and slow (k8) 
clearance components. Clearance was expressed as the half-life time (T'h -ln2/k) for 
the single clearance component in the mono-exponential and for the fast (T'h f) and 
slow (T'h s) clearance components in the bi-exponential analysis. The relative amount 
of tracer cleared by the fast clearance component (IF) was calculated as AF(O)/(AF(O) 
+ A8 (0)). 
The desired quantities (i.e. A(O), k, AF(O), A8 (0), kF and k8) were obtained by 
minimization of the sum of squares by using the so-called Nelder-Mead simplex 
method [Dennis and Woods, 1987; Neider and Mead, 1965]. This is a method for 
multidimensional minimization which does not rely on the use of gradient information. 
Different initial values were used to investigate the convergence properties of the 
method; in this study, similar estimates were obtained for widely different initial 
values. A lower bound on the standard error for each parameter estimate was 
calculated on the basis of the Fisher information matrix. The F-test was used for 
detecting differences between the mono- and bi-exponential fits. 
Mono-exponential functions were fitted to the experimental data of group 3 from 1-60 
min and from 60-120 min and the T'h of the tracer in the lungs during this period was 
calculated. 
Statistical analysis of the mean half-lives between the groups was performed using 
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the Mann-Whitney-Wilcoxon test for unpaired samples. Differences were considered 
statistically significant when p<0.05. 
RESULTS 
All animals could be kept under stable circulatory conditions throughout the 
experiment. The pulmonary distribution of 99"1" c-HSA was uniform in all animals. 
There was a distinct difference in clearance of the tracer between the groups. The 
clearance curve of the controls (group 3) was monophasic of character with a 
statistically significant increase in clearance after applying - after 60 min - the same 
ventilator settings as used in groups 1 and 2 (Fig. 2). The measured half-lives were 
618 ± 241 min and 236 ± 121 min, respectively. All clearance curves of 99'"Tc-HSA 
of the lavaged animals were of a bi-exponential character with bi-exponential curve 
fitting statistically significantly better than mono-exponential in all animals. The H2 of 
the fast compartment was 14.6 ± 6.6 min (mean ± SD) and of the slow 
compartment, 460 ± 167 min. The IF value was 0.27 ± 0.06. Analysis of the surfactant 
treated animals of group 1 resulted in a T'h of the tracer for the fast compartment of 
36.0 ± 6.4 min (mean ± SD); slow compartment, 847.5 ± 143.5 min. These values 
are statistically significantly different from the values of group 2. The relative amount 
of tracer cleared by the last compartment (IF) in these animals was 0.32 ± 0.04. In 
one animal of group 1, however, the monophasic equation analysis fitted better than 
the biphasic equation and the T'h was 515 min. 
Lung lavage decreased blood gas tensions to below 13.3 kPa in all lavaged animals 
(groups 1 and 2). The number of lavages necessary for this decrease was on average 
12 - 14. Subsequent surfactant replacement restored blood gas tensions to almost 
normal values. In group 1 after 120 min blood gas tension values were not statistically 
different from the initial blood gas tension values in this group. There was, however, 
a significant difference in blood gas tension values between groups 2 and 3 (controls) 
after 120 min. 
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Table 1 Blood gas tensions of the three groups during the study period. Values are mean :!::: (SO). 
#: 
@: 
Statistical analysis was performed using the Mann·Whitney~Wilcoxon test for unpaired 
samples. P<O.OS was considered statistically significant. L: lavage; S: surfactant treatment; 
H: healthy. 
Group 2 3 
Time (min) P.a02 PliC02 P.a02 P.aC02 Pll02 P.aC02 
(kPa) (kPa) 
-5 71.13 4.33 71.75 4.51 
(2.4) (0.4) (2.0) (0.5) 
L + S L+S L L H H 
10.46 5.03 
(2.7) (0.6) 
0 62.72 5.35 9.89 4.69 73.19 4.07 
(11.7) (0.5) (2.6) (0.5) (2.2) (0.6) 
30 61.34@ 5.17 23.54' 4.57 75.14 4.81 
(1.3) (0.6) (7.7) (0.7) (2.7) (0.6) 
60 61.9~ 5.40 28.57# 4.77 76.79 5.0 
(13.5) (0.52) (14.2) (0.7) (3.8) (0.4) 
90 62.61@ 5.39 24.6-# 5.27 76.93 5.11 
(15.8) (0.9) (13.7) (0.6) (5.2) (0.2) 
120 66.66@ 5.15 23.8' 5.51 78.75 5.04 
(10.8) (0.5) (11.6) (0.6) (4.3) (0.4) 
statistical significance: group 1 (surfactant treated) compared with group 2 (ravaged). 
statistical significance: group 3 (controls) compared with group 1 
DISCUSSION 
In animals the lung lavage model initially represents a pulmonary surfactant 
deficiency at the alveolar level [Lachmann et al, 1982]. The surfactant layer in the 
alveoli and airways is washed away by the warmed saline, leading to decreased lung 
compliance, atelectatic areas and deterioration of blood gas tensions. When 
mechanical ventilation is applied to these lungs, high peak airway and end-expiratory 
pressures are needed to open up the alveoli and stabilise them during the breathing 
cycle. Many studies have shown that non-optimal ventilation settings often result in 
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epithelial damage on alveolar and bronchiolar levels, leading to further damage and 
deterioration of normal lung function [For review Bos and Lachmann, 1991 b; Kolobow 
et al, 1987; Mascheroni et al, 1988; Nilsson et al, 1978]. This lavage model has also 
been shown to increase alveolar-capillary membrane permeability when measured 
with radio-labelled solutes as, for instance, ssmTc-DTPA [Evander et al, 1987]. 
Exogenous surfactant instillation, however, can restore lung functions and mechanics 
to almost normal when administered immediately after the last lung lavage 
[Kobayashi et al, 1984]. It also restores permeability of the alveolar-capillary barrier, 
as measured by ssmTc-DTPA, indicating that (at least lor ssmTc-DTPA clearance 
measurements), the alveolar surfactant layer is an important rate-limiting factor, as 
well as the alveolar epithelium [Evander et al, 1987, 1988; Jefferies et al, 1988; 
Nieman et al, 1990; Bos et al, 1991a]. 
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Fig. 2 Time-activity curves of the different groups during the study period. Values are given as mean 
::!::: (SO). Dotted line represents group 1 (surfactant treated animals), dashed line group 2 
(lavaged animals) and solid line group 3. 
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Recent reports state that epithelial permeability measurements could be better 
performed using larger molecules whose transfer across the membrane is less 
influenced by physiological factors, as lung volume [Peterson et al, 1989; Barrowcliffe 
et al, 1989]. Barrowclifle and colleagues showed that 99mTc-albumin is a suitable 
tracer molecule for measuring epithelial permeability [Barrowclifle et al, 1989]. 
The control group (group 3) in our study showed a mono-exponential clearance 
curve for 99"'Tc-HSA, which has also been demonstrated by other workers [Peterson 
et al, 1989, Barrowclifle et al, 1989]. The rate of clearance is so slow that one can not 
exclude mechanisms of transport other than diffusion across the alveolar-capillary 
barrier. This transport, for instance, could be due to an active vesicle transport 
system. Passive diffusion through the intercellular pores in the alveolar epithelium is 
not likely as the diameter of these pores is too small for the albumin molecules to 
pass through. The application of high airway pressure ventilation, in order to be able 
to monitor the effects of surfactant treatment, enables passive diffusion to occur and 
clearance rate increases. A possible mechanism could be that the ventilator setting 
after 60 min produced larger pressure-volume swings during the breathing cycle 
(which was confirmed by our finding of an increased expired tidal volume with this 
mode), leading to damage to the epithelium andjor disruption of the normal integrity 
of the pulmonary surfactant system [Bos et al, 1991 a; for review: Bos and Lachmann, 
1991b]. Thus the integrity of the whole alveolar-capillary membrane is altered and 
permeability of the barrier increases. 
The finding of a bi-phasic clearance curve in the lavaged animals (group 2) (see Fig. 
2) is probably caused by a combined effect of the lung lavage procedure inducing 
alveolar surfactant deficiency and the non-optimal mechanical ventilation mode. 
Firstly, lung lavage could affect individual alveoli andjor lung regions to a varying 
degree with differing degrees of damage. There may be two (or more) pools of 
radioactivity which clear the tracer with different half-lives. This would then be the 
same condition as is caused by oleic acid administration which also results in 
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formation of regions of severe lung injury and high epithelial permeability [Peterson 
et al, 1989; Huchon et al, 1988]. 
Secondly, lung lavage could have a transient effect on epithelial permeability. The 
increased permeability, due to a surfactant deficit, quickly returns to normal after a 
few hours with a return to normal surfactant function. This scenario is, however, not 
likely because after 2 h with the applied ventilator settings blood gas tensions had not 
returned to normal. Lowering of PEEP after the study period immediately resulted in 
further deterioration of lung function and blood gas tensions, indicating that there was 
no stabilisation of the lung at end-expiration and surfactant function had therefore not 
restored to normal. 
Thirdly, clearance rates of labelled albumin slowed due to the large exudation of 
plasma fluid into the alveoli. Whenever the membrane is damaged (e.g. by surfactant 
deficiency andjor epithelial damage), complications due to a patho-physiologically 
high permeability can develop with subsequent influx of fluid with a high protein 
concentration, loss of oncotic pressure gradient across the epithelium and 
subsequent formation of pulmonary oedema, limiting diffusion of albumin either way 
[Egan et al, 1977]. Oedema is accompanied with physical thickening olthe alveolar-
capillary membrane due to fluid accumulation in the interstitial space of the barrier, 
thereby lengthening the diffusion path. These latter mechanisms could be of some 
importance in this study because in all animals of group 2, 3 - 8 ml of haemorrhagic 
fluid with a high protein content could easily be extracted from the lungs after 2 h of 
artificial ventilation, indicating at least presence of oedema fluid in the larger airways. 
As has been stated in many reports, the resistance of the epithelium to diffusion of 
all kinds of solutes is ten times that of the endothelium, meaning that the presence 
of oedema fluid can be interpreted as substantial damage to the epithelium [Gorin 
and Stewart, 1979; Staub 1974; Taylor and Gaar, 1970]. 
Another cause for an initial fast clearance of radioactivity from the lungs which has 
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to be considered is dissociation of the label from the albumin molecule. Testing of 
the binding percentage of the labelling showed that before nebulization 98 ± 0.4% 
and after nebulization 99 ± 0.1 o/o of the label was connected to the albumin molecule. 
This indicates that at least no dissociation has taken place in vitro. In vivo 
dissociation of the label, however, can not be entirely excluded although 
pertechnetate cumulates in the gastric mucosa, salivary glands and the thyroid. No 
activity was found in these areas in our study. Peterson and colleagues stated that 
the increase in 99mTc-HSA clearance observed after oleic acid injection was not 
caused by dissociation of the label [Peterson et al, 1989], 
Several workers have shown that exogenous surfactant instillation in lungs reduces 
permeability of the alveolar-capillary membrane [Jobe et al, 1983, 1985; Robertson 
et a!, 1 985]. Surfactant thereby restricts formation of pulmonary oedema and the 
influx of water and proteins into the intra-alveolar air spaces. For these permeability 
measurements, intravenously injected iodine-labelled albumin was used and 
permeability was assessed by measuring the amount of labelled albumin recovered 
in lung lavage fluid. These studies confirmed that the alveolar surfactant layer is of 
major importance to the permeability of the alveolar-capillary barrier. These studies 
also showed that although the epithelium is of greatest importance in limiting free 
diffusion of water and solutes into the alveolar air space, without the surfactant layer 
high permeability of the membrane exists. This indicates that the phospholipid-protein 
layer has a critical sealing-off function. But solar in all these studies investigating the 
influence of surfactant on permeability of the barrier with radio-labelled albumin, the 
route of transfer was from blood to alveolar air space. 
The finding that surfactant restores normal permeability is, in part, confirmed by this 
study. The clearance rates in the surfactant treated animals are smaller than in the 
non-treated group. The clearance curves of almost all animals in group 1, however, 
are of a bi-exponential character, indicating still possible abnormal permeability and 
transfer characteristics of the tracer through the membrane. The initial fast 
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compartment clearance rate of the surfactant treated group is, however, significantly 
slower than that of lavaged animals. The reason behind the multi-exponential 
clearance curves in the surfactant treated animals could be that between the first lung 
lavage and the moment of exogenous surfactant administration, ventilation-induced 
damage already developed. Studies by Nilsson showed that epithelial disruption takes 
place after only a lew breaths in case of surfactant deficiency combined with 
mechanical ventilation [Nilsson et al, 1 978]. Grossmann showed that this damage 
could largely be prevented by direct surfactant instillation to the lungs [Grossman et 
al, 1 986]. This leads us to hypothesise that the fast compartment clearance of the 
tracer in group 2 is caused by epithelial disruption induced by mechanical ventilation, 
which can not be completely restored by the administered surfactant. Surfactant 
instillation, however, probably prevented further damage to the epithelium with 
subsequent, at least partial, restoration of normal integrity of the alveolar-capillary 
membrane. Inhomogeneity of surfactant distribution in the lungs may also have 
caused differences in clearance rates, indicating that alveoli that received no 
surfactant had a higher permeability and those receiving sufficient surfactant probably 
had normal or even decreased permeabilityforthe tracer molecule [Bas et al, 1991a]. 
This feature might enable the evaluation of different surfactant preparations, in which 
the more effective ones will spread more homogeneously in the lungs leading to 
restored monophasic clearance characteristics. 
The slow compartment clearance rate in animals of group 2, however, was almost 
normal despite the presence of a high permeability alveolar oedema and severe 
alveolar surfactant deficiency. This finding makes it hard to discriminate between 
existence of normal permeability due to a normal integrity of the alveolar-capillary 
barrier and a normal clearance due to the probable presence of intra-alveolar 
oedema fluid. 
The data of this study shows that surfactant replacement after lung lavage generally 
restores normal permeability of the alveolar-capillary barrier when using ""'T c-HSA 
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as tracer molecule. Whether 99mTc-HSA is a better tracer than 99mTc-DTPA remains 
to be seen because the clearance rate of ssmTc-HSA also increases sharply after 
applying ventilator modes which increase lung volume. Also the role of oedema 
formation in the lungs, with subsequent protein influx into the alveoli, has still to be 
resolved. 
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PULMONARY CLEARANCE OF"mTc-DTPA DURING HALOTHANE ANAESTHESIA 
SUMMARY 
We studied the integrity of the alveolar-capillary barrier during different forms of 
anaesthesia by measuring the pulmonary clearance of inhaled 99mTc-DTPA. We 
studied four groups of rabbits. Groups I and II were anaesthetised with nembutal 
only and the fractional concentration of inspired oxygen (FiO:J was 0.30 and 1.00, 
respectively. Groups Ill and IV were anaesthetised with 1% halothane and Fi02 was 
0.30 and 0.99, respectively. 99mTc-DTPA was administered as a fine aerosol and the 
clearance of the tracer from the lungs was subsequently measured with a gamma 
camera. The mean half-life of the tracer in the lungs in Groups I-IV was 60, 58, 59, 
and 26 min, respectively. The rapid pulmonary clearance of 99mTc-DTPA in Group IV 
indicates that halothane in combination with high oxygen concentration increases 
the permeability of the alveolar-capillary barrier. This may be due to effects on the 
pulmonary surfactant system andjor the alveolar epithelium. 
INTRODUCTION 
The alveolar-capillary barrier allows rapid diffusion of gases but forms a barrier 
against diffusion of water and solutes. In recent years, non-invasive techniques have 
been developed for the assessment of the integrity of the alveolar-capillary barrier [1]. 
One such technique entails measurement of the pulmonary clearance of technetium-
99m-labelled diethylene triamine pentaacetic acid (molecular weight 492 dalton), 
ssmTc-DTPA [2]. The radioactive tracer is administered as an aerosol and, 
subsequently, the radioactivity is measured over the lungs with a detector. A 
clearance curve is obtained, which refiects the transfer of the tracer across the 
alveolar-capillary barrier. 
The permeability of the alveolar-capillary barrier to 99~c-DTPA is known to increase 
after exposure to various inhaled substances, e.g. smoke [2, 3], aerosolised detergent 
[4] and prolonged exposure to high concentrations of oxygen [5]. 
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Many inhalation anaesthetics are highly lipophilic and have been thought to affect the 
permeability of the biological membranes to water and ions [6]. The purpose of this 
study was to examine the acute effect of halothane and oxygen on the permeability 
of the alveolar-capillary barrier to 99mTc-DTPA. 
MATERIAL AND METHODS 
We studied 20 rabbits under different forms of anaesthesia. Anaesthesia was always 
induced with nembutal 50 mg kg·'. The animals were then tracheotomised and a 
carotid artery was cannulated for blood pressure monitoring. After the preparation, 
anaesthesia was maintained with nembutal in Groups I (n=4) and II (n=6) and with 
halothane (1%) in Groups Ill (n=4) and IV (n=6). All animals were ventilated with a 
Servo Ventilator 900C (Siemens-Elema, Solna, Sweden) at a frequency of 40 min·' 
and tidal volumes of approximately 15 ml kg·'. Inspiratory time was 33% of the 
respiratory cycle, and there was no inspiratory pause. In Groups I and Ill, the 
fractional concentration of inspired oxygen (Fi02) was kept at 0.30, whereas in 
Groups II and IV it was kept at 0.99-1.00. 
In the animals given halothane, blood pressure consistely fell. To compensate for this, 
an infusion of dopamine was started soon after the administration of the halothane. 
The infusion rate was adjusted so that blood pressure was kept at the control level, 
a typical dose rate being 0.3 mg kg·' h·'. The animals were placed under gamma 
camera and were kept under anaesthesia for a minimum of 15 min before the 
measurement of the pulmonary clearance of 99mTc-DTP A. 
A solution of 99mTc-DTPA was prepared using a commercial kit (Technescan DTPA, 
Mallinkrodt Diagnostica, Pet1en, The Netherlands). For administration of the 
radioactive tracer, we nebulized the solution into the inspiratory line of the breathing 
circuit as described previously [7] using an air jet nebulizer (UltraVent, Mallinkrodt 
Diagnostica). The mass median aerodynamic diameter of the particles was 1.7 ..,.m 
as measured with a laser light scattering technique. When a count rate of 
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approximately 400 counts s·' was reached over the lungs (after 1-2 min), the aerosol 
administration was stopped and the clearance measurement started. Gamma camera 
images were obtained in 1-min frames for 20 min and stored in a 64 x 64 image 
matrix in a computer_ When the clearance measurement was completed, the animal 
was sacrificed with an overdose of nembutaL 
Fig. 1 Gamma camera image of a rabbit anaesthetised with nembutal and ventilated with pure 
oxygen. There is uniform distribution of the radioactivity in the lungs. The selection of the 
region of interest is indicated. 
We analysed the data from the clearance measurement by selecting a region of 
interest over both lungs (Fig. 1) and generating a time-activity CUNe. A mono-
exponential function was then fitted to the experimental data and the half-life (T16) of 
the tracer in the lungs calculated. 
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The Tv.! in the four groups was compared with the non-parametric Kruskai-Wallis 
statistics for comparison of multiple groups. 
The study was approved by the local animal investigation committee. 
RESULTS 
All animals could be kept under deep anaesthesia throughout the experiment. In the 
animals anaesthetised with halothane, arterial blood pressure could be maintained at 
a normal level with dopamine infusion. 
In all animals, the distribution of inhaled aerosol was uniform, and there was little 
particle deposition in the large airways (Fig. 1 ). During the measurement, a diffuse 
tissue background radioactivity appeared, and radioactivity could be seen to 
accumulate in the kidneys and the bladder, especially in the animals in Group IV. No 
other site of accumulation of radioactivity was seen. 
Composite clearance curves from the four groups of animals are shown in Fig. 2. The 
clearance curves obtained in Groups I-III are virtually identical, while the animals in 
Group IV have considerably faster pulmonary clearance of ssmTc-DTPA. Excellent 
exponential fits were obtained with correlation coefficients ranging from 0.98-1.00. 
The calculated half-life for the clearance in Groups I-IV was 60, 58, 59 and 26 min, 
respectively (Fig. 3). The Kruskai-Wallis statistical analysis showed a significant 
difference between the groups (P<0.02). 
DISCUSSION 
We have shown that the pulmonary clearance of ssmTc-DTPA is similar during 
barbiturate anaesthesia with an FiO, of 0.30 or 1.00 and halothane anaesthesia and 
Fi02 = 0.30, but considerably increased during halothane anaesthesia in pure oxygen. 
Owing to the limited number of animals studied, small effects of oxygen and 
halothane alone have been overlooked. Such effects would, however, be trivial 
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compared to the combined effect and also compared to the changes in clearance 
rate observed in disease states [8]. The clearance rate observed in the first three 
groups is similar to that previously found in normal rabbits studied under similar 
conditions [9, 10]. 
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Fig. 2 Composite time-activity curves measured over the lungs in rabbits under different forms of 
anaesthesia. Group I (-)was anaesthetised with nembutal , and Fi02 was 0.30. Group ll O was 
also anaesthetised with nembuta!, but Fl02 was 1.00- Group Ill ( .... ) was anaesthetised with 
halothane in 30% 0 2 and Group IV (-,-) with Halothane in 99% 0 2. The curves follow a 
monoexponential course in all groups {note linear scale on the ordinate). 
Provided that the ssmTc-DTPA is administered in an aerosol with sufficiently small 
particles, the tracer will reach the terminal airways and the alveoli and will largely 
reflect solute transport in the gas exchanging region of the lungs. The pulmonary 
clearance of ••mrc-DTPA measured by external detection reflects the rate of transfer 
of the tracer from the air space to the blood. The clearance measurement is 
insensitive to large changes in pulmonary blood flow [11 J, and only small amounts 
of the tracer are cleared via the lymphatics [12]. It has been suggested that the ssmTc-
DTPA could be oxidised in the lung to form free ssmTcO;, which has a considerably 
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faster clearance than 99mTc-DTPA [13]. The fates of the two chemical forms of the 
99mTc in the body are quite different: 99mTc-DTPA is rapidly eliminated by glomerular 
filtration. whereas ssmTc-0; accumulates in the salivary glands, the thyroid and the 
gastric mucosa. The distribution of the radioactivity during measurements clearly 
indicates that ''~c-DTPA is stable under the conditions used in this study. The 
increased rate of pulmonary clearance of ''mTc-DTPA during anaesthesia with 
halothane in oxygen can therefore be interpreted to represent increased permeability 
of the alveolar epithelium to water-soluble molecules [8]. The rate of pulmonary 
clearance of inhaled "~c-DTPA has also been suggested to reflect the functional 
integrity of the pulmonary surfactant system [4, 9, 14, 15]. 
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Fig. 3 Mean half-life (Tlh) for 99mTc-DTPA in the !ungs for the four groups of anima!s. The T\1'2 is much 
shorter in the animals anaesthetised with halothane in 99% 0 2 than in the other groups. 
Pulmonary surfactant consists mainly of phospholipids, which form a monomolecular 
layer at the air-liquid interface in the distal airways of the lung. Pulmonary surfactant 
is believed to be essential for the stability of the alveoli by reducing surface tension 
as the alveolar area is compressed during expiration. Without surfactant, small alveoli 
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would tend to empty into larger ones, and atelectasis would ensue. 
The pulmonary clearance of inhaled 99"'Tc-DTPA has been shown to increase greatly 
after experimental perturbation of the surfactant system. Thus Evander et al [9] 
showed that clearance increased after surfactant depletion by lung lavage and that 
the effect could be partly reversed by surfactant replacement. The pulmonary 
clearance of ssmTc-DTPA also increases after administration of an aerosol containing 
a synthetic detergent which interferes with surfactant function [4]. 
Halothane has been reported to destabilise surfactant monolayers in vitro, but only 
in a high (20%) concentration [16]. The relation between surfactant function in vivo 
and the surface activity measured in vitro is not obvious, and it appears possible that 
halothane might have effects on the surfactant layer at lower concentration in vivo. 
We could not use as high concentrations of halothane in vivo as used in v·rrro, and 
do not know whether they would not affect the pulmonary clearance of inhaled 99mTc-
DTPA. Anaesthesia with 1% halothane and 30% oxygen did not affect the pulmonary 
clearance of inhaled ''mTc-DTPA. 
Exposure to pure oxygen causes lung damage pathologically characterised by 
atelectasis, oedema, alveolar haemorrhage and hyalinization of alveolar membranes 
[17]. The pathogenesis is not completely understood, but may involve increased 
formation of oxygen radicals, leading to peroxidation of surfactant and membrane 
lipids [17, 18]. Exposure to pure oxygen reduces the amount and impairs surface 
activity of pulmonary phospholipids, and also reduces incorporation of radiolabelled 
precursors into pulmonary phospholipids [19-22]. Measurements of pulmonary 
phospholipids and surface activity have generally been made after at least 48 h 
exposure to oxygen, and we are not aware of any studies of the acute effect. The 
permeability of the alveolar epithelium to cytochrome c (molecular weight 12,523 
daltons) is increased after 48 h of exposure to pure oxygen, before there is any 
evidence of oedema formation [23]. No information concerning shorter periods of 
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exposure was given in this study. Several drugs are known to augment oxygen 
toxicity in general [17] and specifically the adverse effects on phospholipid synthesis 
[18]. 
In a previous study of the effects of oxygen on the pulmonary clearance of inhaled 
''"'Tc-DTPA, Griffith et al [5] found an increased clearance rate in normal subjects 
after exposure to 50% oxygen for 48 h. The short exposure to pure oxygen in the 
animals anaesthetised with barbiturate in the present study did not result in increased 
pulmonary clearance of ''"'Tc-DTPA. This is in agreement with previous findings [4, 
9, 10]. Exposure to pure oxygen only thus appears to have no acute effect on the 
transfer of small solutes across the alveolar-capillary barrier. 
The increased rate of pulmonary clearance of 99mTc-DTPA during anaesthesia with 1% 
halothane in oxygen is likely to be caused by combined effects of the two gases on 
the pulmonary surfactant andjor alveolar epithelium. To the extent that the increased 
clearance of 99mTc-DTPA reflects damage to the surfactant system or the epithelium, 
this may be a pathogenetic mechanism in the development of several per- and 
postoperative complications, e.g. atelectasis and pulmonary oedema. Further studies 
of the effects of various anaesthetics and oxygen on the alveolar-capillary barrier 
therefore seem warranted. 
In conclusion, we have shown that the pulmonary clearance of 99mTc-DTPA is 
unaffected by the short-term ventilation with pure oxygen during barbiturate 
anaesthesia. Anaesthesia with 1% halothane and an Fi02 of 0.30 does not affect the 
clearance rate, but when halothane is given in pure oxygen, the clearance rate 
increases markedly. The effect of halothane and oxygen on the pulmonary clearance 
of 99"'Tc-DTPA may reflect adverse effects of the gases on the pulmonary surfactant 
system and for the alveolar epithelium. 
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INTEGRITY OF THE ALVEOLAR-CAPILLARY BARRIER AND ALVEOLAR 
SURFACTANT SYSTEM IN SMOKERS 
SUMMARY 
The purpose of this study was to examine the integrity of the alveolar-capillary barrier 
in smokers and non-smokers. Alveolar-capillary solute transfer was measured with 
99mTc-DTPA. Transudation of albumin and urea was measured in bronchoalveolar 
lavage fluid. The integrity of the alveolar surfactant system was assessed by 
measurement of the surface activity and by the measurement of the yield of 
phospholipids in alveolar lavage fluid. The mean decay constant for the pulmonary 
clearance of 99mTc-DTPA was 0.028 min·' in the smokers and 0.009 min·' in the 
smokers (p<0.001). The recovery of albumin and urea in alveolar lavage fluid were, 
however, very similar in the two groups. The surface activity of alveolar lavage fluid 
as well as the yield of phospholipids was significantly reduced in the smokers 
relative to the non-smokers. The rate constant for the pulmonary clearance of 99mTc-
DTPA correlated with variables reflecting surfactant function. The study shows that 
the increased alveolar-capillary transfer of 99mTc-DTPA in smokers is not 
accompanied by increased transudation of small or large molecules into the alveoli. 
The findings support the hypothesis that increased clearance of 99mTc-DTPA in 
smokers is related to surfactant dysfunction. 
INTRODUCTION 
Alveolar air is separated from the pulmonary capillary blood by a delicate barrier, the 
integrity of which is crucially important for the liquid homeostasis in the lung. The 
alveolar-capillary barrier comprises the alveolar surfactant system, the alveolar 
epithelium, basement membrane and the capillary endothelium. The functional 
integrity of the barrier can be studied by measurement of the transfer of solutes from 
the alveolus to the blood or the transudation of solutes from the capillaries to the air 
space. 
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The most common technique for studies of solute transfer from the air space to the 
blood is the measurement of pulmonary clearance of 99mTc-labelled diethylene 
triamine pentaacetate {"9mTc-DTPA) [1]. This hydrophillic molecule has a molecular 
weight of 492 dalton. The tracer is administered in aerosol form and subsequently the 
clearance of the tracer from the lungs is measured by external counting over the 
lungs. The rate of clearance refiects the transfer of the tracer across the alveolar-
capillary barrier. Several groups have shown that the rate of pulmonary clearance of 
ssmTc-DTPA is much faster in smoking than in non-smoking subjects [2-6]. The 
mechanism lor the increased alveolar-capillary barrier permeability in smokers is not 
clear. It has been suggested to reflect damage to the alveolar epithelium [1] but also 
abnormal surfactant function in the alveoli [7]. 
Indications of transudation of solutes from the capillaries into the alveoli can be 
obtained by analysis of solutes in bronchoalveolar lavage fluid [8]. The yield of 
albumin in lavage fluid has thus been measured in smokers in efforts to assess the 
properties of the alveolar-capillary barrier [9-13]. It has recently been shown that urea 
(mw=60 dalton) readily diffuses from the blood and the interstitial space into lavage 
fluid during the procedure [14-16]. This suggests that the yield of urea in lavage 
effluent could be a suitable indicator of the alveolar-capillary barrier permeability. 
provided the dwell time of fluid in the alveoli is controlled. We are not aware of any 
studies of the yield of urea at bronchoalveolar lavage in smokers nor of any attempt 
to correlate measurements of pulmonary clearance of ssmTc-DTPA with indicators of 
increased alveolar-capillary barrier permeability at bronchoalveolar lavage in smokers. 
It is well established that the yield of surfactant phospholipids in bronchoalveolar 
lavage effluents is reduced in smokers [12. 17]. The rapid pulmonary clearance of 
99mTc-DTPA has been suggested to be related to impaired surfactant function. but 
there are no studies of clearance in relation to measurements of phospholipids in 
lavage fiuid. 
The purpose of this study was to relate measurements of pulmonary clearance of 
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"1"c-DTPA to indicators of alveolar-capillary barrier permeability and to indices of 
surfactant function obtained at bronchoalveolar lavage in normal smokers and non-
smokers. 
MATERIALS AND METHODS 
SUBJECTS 
We studied 13 current smokers and nine life long non-smokers. None of the smokers 
had a history of chronic bronchitis. The physical characteristics of the two groups of 
subjects were similar (table 1 ). Physical examination showed nothing abnormal in any 
of the subjects. 
SPIROMETRY 
A spirometry including vital capacity (VC) and forced expiratory lung volume (FEV,) 
was performed with a spirometer based on pneumotachography (Vitalograph 
Compact, Vitalograph Ltd., Buckingham, England). The results were related to 
predicted values [18]. 
PULMONARY CLEARANCE OF 99mTc-DTPA 
A solution of 99mTc-DTPA was prepared from a commercially available kit (Pentetate 
II, Amersham International, Amersham, U.K.) and nebulized with an air jet nebulizer 
(UitraVent, Mallinckrodt Diagnostica, Petten, the Netherlands). The mass median 
diameter of the particles was 1.7 11m. The subjects inhaled the aerosol by quiet tidal 
breathing for 1 to 2 minU1es whilst seated in front of a gamma camera (Maxicamera 
400T, General Electric Co., Milwaukee, Wisconsin, USA) until a count rate of 
approximately 2000 countsjs had been reached. The subjects were then immediately 
placed in the supine position on a thin couch and the gamma camera placed under 
the couch so as to obtain an image of the lungs in the posterior view. The gamma 
camera was interfaced with a compU1er system and the measurement of radioactivity 
over the chest were stored in one minute frames for 30 minU1es in a 64 x 64 image 
matrix. After approximately 20 minU1es, a small amount of 99mTc-DTPA was injected 
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intravenously to enable a correction for non-pulmonary radioactivity to be performed. 
The measurements were analysed by selecting a region of interest enclosing both 
lungs and generating a time-activity curve. The correction for non-pulmonary 
radioactivity was performed as described by Barrowcliffe and colleagues [19] using 
a back-ground region selected over the great vessels in the abdomen. An exponential 
function 
where Ao is the count rate at time zero and A is the radioactivity at any time t was 
fitted to the experimental data from 1 to 20 min. The slope was expressed as the 
decay constant (k). 
BRONCHOALVEOLAR LAVAGE 
Bronchoalveolar lavage was performed as previously described in detail [20]. After 
premedication with morphine and scopolamine and local anaesthesia with lidocaine, 
the fiberoptic bronchoscope (Olympus SF 1 T 1 0) was loosely wedged in an anterior 
subsegment of the right middle or lower lobe. Three 50 ml aliquots of tepid sterile 
saline were sequentially infused and then gently aspirated and collected in two 
separate containers. The first aliquot was considered to represent to a great extent 
a bronchial wash. The following two aliquots were pooled and considered more to 
represent alveolar wash. The lavage procedure was standardised as far as possible 
and the time from infusion to aspiration of saline (dwell time) recorded. The lavage 
fluid was kept on ice until centrifuged (4" C, 200g) lor ten minutes. The supernatant 
was removed from the cell pellet and kept frozen at -70° C until analysed. 
MEASUREMENT OF UREA AND ALBUMIN IN LAVAGE FLUID 
The concentrations of urea and albumin were measured in bronchial wash fluid as 
well as in bronchoalveolar lavage fluid. In the bronchial wash fluid, urea and albumin 
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concentrations were measured in six non-smokers. Urea and albumin concentrations 
were measured in unconcentrated lavage fluid [21, 23]. The total amount of urea and 
albumin in the lavage fluid was calculated by multiplying the concentration with the 
volume of aspirated fluid. The plasma concentration of urea and albumin were also 
measured in venous blood samples. 
MEASUREMENT OF PHOSPHOLIPIDS IN LAVAGE FLUID 
The concentration of phosphatidyl choline was measured in bronchoalveolar lavage 
fiuid. lipids were extracted twice with two fold volume of chloroform: methanol (2:1) 
and once in chloroform. The extract was evaporated to dryness at 40°C in a rotary 
evaporator under vacuum. The residue was dissolved .in 2.0 ml of chloroform: 
methanol (2:1 ). 
Phospholipids were separated by thin layer chromatography on 250 11m thick gel 
plates (Kieselgel 60 F254, Merck). The solvent systems used were chloroform j 
methanol j water (65/25/4) [24, 25] and chloroformjmethanoljacetic acid/water 
(100/60/16/8) [25, 26]. To visualise the phospholipid fractions, the chromatogram 
was exposed to iodine vapour. Phosphatidyl choline (PC) was localised in the 
chromatogram with the help of side standards of dipalmitoyl phosphatidyl choline 
(DPPC; Sigma Chemical Company, StLouis, MO, USA) spotted on each plate. Three 
standards of 10, 20 and 30 llg of DPPC were used. Spots in the chromatograms 
corresponding to DPPC were quantified using a densimeter coupled with an 
integrator (wave length 366 nm). The PC recovered from smokers and non-smokers 
was essentially DPPC as confirmed by gas-liquid chromatography (contained > 73% 
palmitic acid). 
MEASUREMENT OF SURFACE ACTIVITY OF LAVAGE FLUID 
The ability of bronchoalveolar lavage fluid to lower surface tension at an air-water 
interface was measured on a Wilhelmy balance (Wilhelmy-Tensiometer, Biegler 
Electronic, Mauerbach, Austria). 0.8 ml of lavage fluid was added to the saline filled 
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trough and surface tension recorded with a platinum plate while the area was altered 
by continuous cycling from 100 to 20% at a cycle speed of 0.33 min·'. Maximum 
(gammam~l and minimum (gammam1,) surface tension were recorded during the filth 
cycle. 
STATISTICAL ANALYSIS 
Differences between groups were investigated with Student's t-test. Relation between 
variables was assessed by linear regression analysis. The level of significance was 
set at p=0.05. 
RESULTS 
There were no substantial differences in physical characteristics between smokers 
and non-smokers (table 1 ). There was a wide range in the cumulative tobacco 
consumption of the smokers. All subjects were essentially normal at spirometry, and 
there were no significant differences between the two groups. 
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Fig. 1 Rate constant for the pulmonary clearance of ssmTc-DTPA in the two groups of subjects. 
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Table 1 Characteristics of subjects studied, results of carboxyhaemoglobin measurements and results 
of spirometry. 
n 
Age (years) 
Height (m) 
Weight (kg) 
Smoking history (pack years) 
COHb (%) 
VC (% pred.) 
FEV1 (% pred.) 
0 1 
Non-smokers 
9 
37 (11) 
1.79 (0.07) 
72 (10) 
0 
0.62 (0.30) 
103 (14) 
106 (14) 
2 3 4 
Total PC (mg) 
Smokers 
13 
35 (12) 
1.82 (0.07) 
79 (12) 
17 (12) 
2.58 (1.1) 
96 (13) 
100 (10) 
5 6 
Fig. 2 Maximum {filled symbols) and minimum (open symbols) surface tension of alveolar lavage 
fluid versus total yield of phospholipids in alveolar lavage fluid. There was a significant 
correlation for maximum (r=-0.63) as well as for minimum (r=-0.66) surface tension. 
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Pulmonary clearance of 99mTc-DTPA was much faster in the smokers than in the non-
smokers (fig. 1). The decay constant ranged from 0.014 to 0.054 min·' with a mean 
of 0.028 min·' in the smokers compared to a range from 0.006 to 0.016 min·' and a 
mean of 0.009 min·' in the non-smokers (p < 0.001). There was thus a small overlap 
between the groups. 
Dwell time and recovery of lavage fluid were very similar in the two groups of 
subjects (table 2). In the bronchial wash fluid, the concentration as well as the total 
amount of urea was higher in smokers than in non-smokers, but the difference did 
not quite reach statistical significance. The concentration of albumin in bronchial 
wash fluid was very similar in the two groups. In bronchoalveolar lavage fluid, the 
concentration of both urea and albumin were virtually identical in non-smokers and 
smokers. The plasma concentrations of urea and albumin were also similar in non-
smokers and smokers; urea 4.8 ± 0.8 mmol 1·' and 4.4 ± 0.7 mmol r', respectively 
and albumin 0.68 ± 0.03 mmol 1·1 and 0.65 ± 0.04 mmol r', respectively. 
The concentration of phosphatidyl choline in alveolar lavage fluid was measured 
successfully in six non-smokers and in 10 smokers. Measurements of surface activity 
were obtained in six non-smokers and in 11 smokers. The yield of phospholipids in 
bronchoalveolar lavage fluid was approximately twice as high in non-smokers as in 
smokers (table 3). The concentration (p<0.01) as well as the total amount (p<0.05) 
of phosphatidyl choline was significantly greater in non-smokers than in smokers. The 
surface activity of alveolar lavage fluid was also lower in non-smokers than in 
smokers (table 3). Both gammam1, and gammam~ were significantly lower in non-
smokers than in smokers. 
- 129-
Table 2 Urea and albumin concentration measurements in lavage fluid. 
Non~smokers Smokers 
Bronchial wash 
Recovery (ml) 15 (5) 17 (6) 
Dwell time (min) 1.8 (0.5) 1.6 (0.5) 
Urea concentration (mmoljl) 0.03 (0.01) 0.06 (0.04) 
Total urea (mmol) 0.51 (0.26) 1.19 (1.19) 
Albumin concentration (jLmoljl) 1.7 (0.5) 1.8 (0.6) 
Total albumin (!Lmol) 31 (12) 32 (12) 
Alveolar wash 
Recovery (ml) 69 (17.4) 68 (13.8) 
Dwell time (min) 3.7 (0.9) 3.2 (1.1) 
Urea concentration (mmoljl) 0.08 (0.03) 0.08 (0.04) 
Total urea (mmol) 5.04 (1.52) 5.21 (2.2) 
Albumin concentration (!Lmol/1) 1.7 (0.6) 1.7 (0.8) 
Total album·ln (jLmol) 116(54) 119 (57) 
Measurements of the yield of phosphatidyl choline and measurements of surface 
activhy of the bronchoalveolar lavage fluid can be reg<l;rded as indicators of the 
functional integrity of the surfactant system, and we were interested in possible 
correlations between the measurements. When the lavage PC concentration was 
correlated with measurements of surface activity, a non-smoker with a PC 
concentration of 100.0 mg mr' was a clear outlier. If this value was excluded, PC 
concentration correlated inversely whh gammam~ (r=-0.68, p<0.05) and gammam,c 
(r=-0.84, p<0.01). In all subjects, the total amount of PC recovered correlated 
inversely with gammamox (r=-0.63, p<0.05) and gammamic (r=-0.66, p<0.05, fig.2). 
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Table 3 Phospholipid (PC) concentration measurements and surface activity measurements in lavage 
fluid. 
PC concentration (mgfml) 
To1al PC (mg) 
9m~ (mNjm) 
9min (mNfm) 
0.03 
,--. 
= 
·a 0.02 
--
'-" 
..::.:: 
O.Ql 
0 1 
Non·smokers 
60 (31) 
3.86 (0.12) 
62.1 (6.0) 
28.6 (5.2) 
2 3 4 
Total PC (mg) 
Smokers 
(30 (9) 
2.08 (0.65) 
67.2 (3.2) 
37.9 (5.2) 
5 6 
Fig. 3 Rate constant for the pulmonary clearance of ssmTc-DTPA versus the total yield of 
phospholipids in alveolar lavage f!uid. 
We found several correlations between the rate of pulmonary clearance of 99mTc-
DTPA and variables reflecting the properties of the surfactant system. The rate 
constant k thus correlated inversely with the lavage PC concentration (r=-0.62. 
p<0.05) as well as the total amount of PC recovered (r=-0.77, p<0.01, fig. 3) . 
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DISCUSSION 
The alveolar-capillary barrier comprises the alveolar surfactant system, the alveolar 
epithelium, the basement membrane and the capillary endothelium. in studies of fluid 
filled lungs the alveolar epithelium has been shown to be much less permeable to 
small water soluble molecules than the capillary endothelium, whether the tracer 
substance is introduced into the alveolar space or into the blood [26]. ssmTc-DTPA 
is a hydrophillic compound and is considered to be transported by simple diffusion 
via the paracellular route. The increased rate of clearance observed in smokers is 
often, in accordance with studies of solute transfer in fluid filled lungs, interpreted to 
represent a high permeability of the alveolar epithelium to ssmTc-DTPA. Since the 
alveolar epithelium is the major barrier to solute flux also from the blood into the 
alveoli [14, 26], increased permeability of the epithelium might be expected to cause 
increased transfer of solutes into bronchoalveolar lavage fluid. When a tracer such 
as 99mTc-DTPA is introduced into the alveoli in aerosol form, the alveolar surfactant 
system is functionally intact, in contrast to the situation in the fluid filled lung. The 
pulmonary clearance of 99mTc-DTPA is increased in experimental states of surfactant 
dysfunction [27, 28] and reduced by experimentally increased alveolar content [29]. 
Recent speculations have suggested the rapid clearance in smokers to be related to 
abnormal surfactant function [7]. This study was designed to investigate the relation 
between pulmonary clearance ol 99mTc-DTPA and indices of solute transfer from the 
pulmonary capillaries and alveolar surfactant function obtained at bronchoalveolar 
lavage. We found that while the transfer of 99mTc-DTPA from the alveoli to the blood 
is much laster in smokers than in non-smokers, there is no indication of increased 
leakage of urea or albumin from the pulmonary circulation to the alveoli during 
bronchoalveolar lavage in smokers. Indices of alveolar surfactant function are 
abnormal in smokers and correlate with the rate of pulmonary clearance of 99mTc-
DTPA. 
The yield of urea and albumin in bronchoalveolar lavage fluid have long been used 
as indicators of the permeability of the air-blood barrier [8]. Urea is a small molecule 
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and is able to diffuse through the intact cell membranes [30]. It is well established 
that urea diffuses into lavage fluid in appreciable amounts during a few minutes of 
fluid dwell time in the alveoli [14, 15, 16, 31]. The concentration of urea in alveolar 
lavage fluid has previously been shown to be increased in patients with interstitial 
lung disease [15, 20]. We found the alveolar lavage fluid concentration of urea to be 
approximately 2% of the serum concentration in both smokers and non-smokers. A 
first approximation of the rate of transfer of urea from blood and interstitial tissue can 
be obtained from a simple two compartment model assuming first order kinetics 
(Appendix). The calculations result in similar rate constants in smokers and non-
smokers. Furthermore, the rate constants for urea are of the same of magnitude as 
the rate constants for ssmTc-DTPA found in the non-smokers. The main barrier for the 
transport of urea from blood to the fluid filled alveolus is the alveolar epithelium [14, 
26]. If the main mechanism for the increased rate of alveolar-capillary transfer of 
ssmTc-DTPA in the smokers were increased permeability of the alveolar epithelium, it 
appears likely that the rate of transfer of urea from blood to air space would also be 
increased. 
The rate of transfer of albumin from blood into fiuid filled alveolus is much lower than 
that of urea [14, 16, 26] and very little albumin diffuses into alveolar lavage fluid under 
normal conditions. Unless there are gross changes ofthe permeability of the alveolar-
capillary barrier, the use of albumin concentration in lavage fluid as an index of 
permeability relies on changes in the amount of albumin in the alveoli at steady state. 
The yield of albumin at bronchoalveolar lavage in smokers has been studied with 
conflicting results. Low and colleagues [12] found the ratio between the con-
centration of albumin in plasma and lavage fluid to be significantly reduced in 
smokers compared to non-smokers. Bell and colleagues [32] found the total amount 
of protein recovered by lavage to be considerably increased in smokers. In contrast, 
Reynolds and colleagues [9] and Warr and colleagues [10] found no differences in 
the yield of albumin between smokers and non-smokers, and Banks and colleagues 
[13] found a tendency for the yield of albumin to be reduced in smokers. Thompson 
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and colleagues [11] measured albumin concentration in bronchial and alveolar lavage 
fluid separately in normal smokers and non-smokers as well as in patients with 
chronic bronchitis. They found no differences between normal smokers and non-
smokers. In the patients with chronic bronchitis, albumin concentration was increased 
in the bronchial but reduced in the alveolar lavage fluid. Our finding of similar albumin 
yield in normal smokers and non-smokers at bronchoalveolar lavages thus agrees 
with most previous studies and give no indication of increased transudation of 
albumin from the pulmonary capillaries. 
Low yield of surfactant phospholipids from smokers was first described by Finley and 
Ladman [17] and subsequently by Low and colleagues [12]. In an experimental 
study, Le Mesurier et al. [33] showed the lavage yield of phospholipids to be reduced 
in rats exposed to cigarette smoke. Abnormal surface activity of lavage fluid from 
smokers has been described by Cook and Webb [34]. In general agreement with 
these studies, we found a lower yield of phospholipids and reduced surface activity 
of alveolar lavage fluid in smokers than in non-smokers. Surface tension, as 
measured in this study, may reflect quantitative and/or qualitive abnormalities of 
alveolar surfactant. Correlation analysis showed the variance in phospholipid 
concentration to explain some 40% of the variance in maximum and minimum 
surface tension of lavage fluid. This may indicate that there are also qualitive 
differences in the properties of alveolar surfactant between smokers and non-
smokers. Some support for this concept is provided by the finding that cigarette 
smoke impairs surface activity of lavage fluid in vitro [35]. 
The rate constant forthe alveolar-capillary transfer of 99mTc-DTPA correlated with both 
measurements of phospholipid concentration and the surface activity of lavage fluid. 
These correlations do not, of course, prove a causal relationship between surfactant 
dysfunction and the pulmonary clearance of 99mTc-DTPA. Taken together with the 
findings of normal lavage fluid concentrations of urea and albumin they do, however, 
support the hypothesis that abnormal clearance of 99mTc-DTPA in smokers could be 
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more related to surfactant function than to permeability of the alveolar epithelium. 
There are several possible mechanisms whereby surfactant dysfunction could 
influence the absorption of 99"'Tc-DTPA [36]. Surfactant could affect the spreading of 
the tracer in the aqueous hypophase in the alveolus. If permeability varies within the 
alveolus, e.g. is greater in the corners, this would affect the clearance rate. 
In summary, we found increased rate of alveolar-capillary transfer of 99"'Tc-DTPA in 
smokers relative to non-smokers, but no indication of increased transfer of urea or 
albumin from the blood into the alveoli at lavage. The rate of pulmonary clearance 
of ssmTc-DTPA correlated with indices of surfactant function obtained at alveolar 
lavage, supporting the hypothesis that increased clearance of 99"'Tc-DTPA in smokers 
is related to surfactant dysfunction. 
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APPENDIX 
The rate of diffusion of urea from blood and interstitial fluid into alveolar lavage fluid 
was estimated in a simple two compartment model. Urea is assumed to diffuse from 
a body water compartment with a constant concentration of urea corresponding to 
the plasma concentration into an alveolar lavage fluid compartment. Since the 
concentration of urea in lavage fluid amounted to ·only 2% of the plasma 
concentration, the change in concentration gradient was neglected. The increase in 
urea concentration of lavage fluid (U,) with time (t) is described by 
where UP is the plasma concentration of urea and k the rate constant. Using the 
mean values of lavage and plasma concentration of urea found in non-smokers yields 
a rate constant of 0.0047. The corresponding value for smokers is 0.0057. 
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SUMMARY AND CONCLUSION 
This thesis focuses on the importance of an intact pulmonary surfactant system and 
investigates the ways in which this system is influenced by various components of 
modern medicine, including mechanical ventilation and anaesthetic procedures. 
Further as permeability of the alveolar-capillary membrane is a reliable and sensitive 
indicator of the functional integrity of the surfactant system, clearance rates of radio-
labelled solutes were measured in order to establish the effects of mechanical 
ventilation, anaesthetic procedures and smoking on surfactant function. 
It is established that an optimally functioning surfactant system is crucial for 
maintenance of normal gas exchange in human lungs. The alveolar surfactant layer 
is an integral part of the alveolar-capillary membrane which prevents alveolar collapse 
and allows rapid diffusion of oxygen and carbon dioxide but restricts transfer of 
proteins and other molecules into the alveolar airspace. Alterations in the integrity of 
the surfactant layer therefore influences the functional integrity of the whole barrier. 
There are various methods for testing the integrity of the surfactant layer and the 
pulmonary surfactant system in general. These include: pulmonary compliance 
measurements, biochemical and biophysical analysis of lung extracts and pulmonary 
99mTc-DTPA clearance measurement. This thesis focuses on the latter technique in 
assessing the state of the pulmonary surfactant system. Chapter 1 presents a general 
introduction to the technique. 
In all experimental studies, the animals were anaesthetised and paralysed so that the 
use of artificial ventilation was imperative. Due to the unphysiological nature of 
mechanical ventilation, use of these techniques has direct/indirect effects on the 
structure of the lung and on the pulmonary surfactant system. The influences of 
different modes of ventilation on the surfactant layer is discussed in chapter 2 and 
a possible mechanism of how artificial ventilation disrupts the surfactant system is 
presented. The mode of ventilation used under conditions of pulmonary surfactant 
deficiency is even more crucial than in normal healthy lungs. Different modes can 
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cause widely differing effects on the restoration processes of the surfactant system 
in the lungs. In chapter 3, this hypothesis was tested using the pulmonary 99mTc-
DTPA clearance technique in rabbits. The studied mode$ were high frequency jet 
ventilation (HFJV) at 2 and 15 Hz and volume controlled PEEP ventilation at 0.5 Hz 
in surfactant deficient and healthy lungs. The results show that HFJV at 15 Hz has the 
lowest clearance rate for 99mTc-DTPA and h appears that HFJV at 15 Hz provides the 
best conditions for restoration of the pulmonary surfactant system. HFJV at 2 Hz 
proved to be highly deleterious to the lungs: histology evidenced extensive damage 
to the lungs and the clearance rate of 99mTc-DTPA was the fastest of all studied 
modes indicating a totally disrupted alveolar-capillary membrane. 
The hypothesis that the ou1come of these clearance measurements is dependent on 
the integrity of the surfactant system provided the rationale for the study described 
in chapter 4. Whenever the alveolar surfactant layer is removed, depleted or 
damaged, the clearance rate of 99mTc-DTPA increases dramatically. The opposite 
should occur when the alveolar surfactant content is experimentally increased. This 
was achieved by administration of Ambroxol0 intravenously or exogenous natural 
surfactant intratracheally. The results of this study led to the conclusion that an 
increased alveolar surfactant content does indeed slow the clearance rate of 99mTc-
DTPA. 
Blood gas tensions are one of the most important parameters on which to base or 
adjust ventilatory strategy, especially in the intensive care unit (I.C.U.) But the 
question rises whether it is the most sensitive parameter to indicate the beginning of 
acute respiratory insufficiency, or are other lung function tests available. Under these 
conditions, 99mTc-DTPA clearance measurements were compared with blood gas 
tension measurements. This study, described in chapter 5, shows that blood gas 
tensions are not always sensitive enough to accurately describe the status of the 
surfactant system under mechanical ventilation. Whereas blood gases had restored 
to normal, permeability measurements of the alveolar-capillary membrane using 
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"'Tc-DTPA still showed a highly abnormal situation. The fact that ssmTc-DTPA 
clearance measurements are so sensitive to changes in the surfactant layer could be 
of importance in the management of ventilated patients in the I.C.U. 
The proven sensitivity to changes in the permeability of the alveolar-capillary 
membrane is at the same time reason to question the usefulness of ssmTc-DTPA to 
perform permeability measurements. It is suggested that ssmTc-DTPA is too small a 
molecule to enable discrimination between intermediate and severe damage to the 
alveolar-capillary membrane and therefore the use of larger molecules as, for instance 
ssmTc-labelled human serum albumin (HSA), is advocated. In chapter 6, a study is 
presented in which the dependency of the pulmonary clearance of ssmTc-HSA is 
investigated in rabbits receiving, and not receiving exogenous surfactant replacement 
therapy after lung lavage. It was concluded that the pulmonary clearance of ssmTc-
HSA is at least partially dependent on the integrity of the surfactant system. The 
study also showed that high airway pressure ventilation significantly alters 
permeability for ssmTc-HSA and that the formation or existence of pulmonary oedema 
has some unknown infiuences on the diffusion rate of ssmTc-HSA across the alveolar-
capillary barrier. This leads us to suggest that the use of 99mTc-HSA does not provide 
many advantages over the use of 99"'T c-DTPA and that for each molecule there 
probably is a specffic situation for application. 
Another extensively used feature of modern medicine that may have a deleterious 
effect on the pulmonary surfactant system is the use of volatile anaesthetic vapours 
as, for instance, halothane. In chapter 7, the effects of 1.0% halothane with 30% and 
99% oxygen on the permeability of the alveolar-capillary membrane was investigated 
by measuring the ssmTc-DTPA clearance rate. Halothane mixed with pure oxygen 
significantly increased the permeability ofthe alveolar-capillary membrane, suggesting 
that this combination of gases altered the structure cf the alveolar epithelium andjor 
the integrity of the alveolar surfactant layer. This could be a factor which contributes 
to the development of various per- and postoperative complications, such as lung 
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atelectasis and pulmonary oedema which. in severe cases. could necessitate 
prolonged mechanical ventilation after anaesthesia. 
In the study presented in chapter 13 the integrity of the alveolar-capillary membrane 
is examined in smokers and non-smokers. Pulmonary ssmTc-DTPA clearance rate was 
measured, as well as transudation of albumin and urea in bronchoalveolar lavage 
fluid. The integrity of the pulmonary surfactant system was assessed by surface 
tension measurements and phospholipid yield measurements in lavage fluids. The 
latter measurements were clearly reduced in smokers. The rate constant for :he 
pulmonary clearance of ''mTc-DTPA correlated with variables reflecting surfactant 
function. The increase in clearance rate of 99mTc-DTPA was not accompanied by an 
increase in transudation of large and small molecules, e.g. albumin and urea, into the 
alveoli. These findings support the hypothesis that increased clearance of ssmTc-DTPA 
in smokers is related to surfactant dysfunction. 
The studies presented in this thesis indicate the importance of the pulmonary 
surfactant system for pulmonary clearance rate measurements using "mTc-iabeilec 
molecules as, lor instance DTPA and HSA. This noninvasive and simple tecnnique 
could therefore, with certain limitations, be an important new tool to assess the 
integrity of the surfactant system. 
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SAMENVATTING EN CONCLUSIES 
Dit proelschrift richt zich op het belang van een intact long surfactant systeem en 
onderzocht wordt in hoeverre dit systeem be'lnvloed wordt door verschillende 
medische behandelingen, inclusief kunstmatige beademing en anesthesie procedures. 
Daar de permeabiliteit van de alveolus-capillair membraan een betrouwbare en 
gevoelige parameter is voor de functionele integriteit van het surfactant systeem, is 
deze gemeten d.m.v. de klaring snelheden van radio-actief gemaakte stoffen. 
Een optimaal functionerend surfactant systeem is cruciaal voor de gas uitwisseling 
in de longen. De surfactant laag in de longalveolus maakt deel uit van de alveolus-
capillair membraan en voorkomt het samenklappen van de alveolus en maakt snelle 
diffusie van zuurstof en kooldioxyde mogelijk. Tegelijkertijd echter beperkt het de 
transfer mogelijkheden van eiwitten en andere moleculen van de bloedbaan naar de 
alveolaire luchtruimte. Veranderingen in de integriteit van de surfactant laag bepaalt 
daardoor de integriteit van de gehele barriere. Om de lunctionele staat van de 
surfactant laag te testen zijn verschillende technieken beschikbaar: long compliantie 
metingen, biochemische en biophysische analyse van long extracten en long 99"'Tc-
DTPA klaring metingen. Aile onderzoeken m.b.t het surfactant systeem in dit 
proefschrift zijn uitgevoerd d.m.v deze laatste techniek. In hoofdstuk 1 wordt een 
algemene introductie gegeven van deze methode. 
In aile experimenten waren de konijnen onder anesthesie en verlamd zodat 
kunstmatige beademing noodzakelijk was om de dieren in Ieven te houden. Gezien 
het on-fysiologische karakter van kunstmatige beademing is het logisch te 
veronderstellen dat gebruik van deze technieken directe of indirecte effecten zal 
hebben op de structuur van de long en het surfactant systeem in het bijzonder. De 
invloeden van deverschillende beademingstechnieken wordt besproken in hoofdstuk 
2. In dit hoofdstuk wordt oak een mogelijk mechanisme aangegeven over hoe 
beademing het surfactant systeem verstoort. De keuze van beademing wordt nog 
belangrijker als het longsurfactant systeem al beschadigd is en het is mogelijk dat de 
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diverse method en verschillende mogelijkheden bieden voor restauratie processen. In 
hoofdstuk 3 is deze hypothese getoetst met behul p van konijnen. De bestud eerd e 
beademingsmethoden waren: Hoogfrequentie jet beademing {frequentie van 2 en 15 
Herz) (HFJV) en volume gecontroleerde PEEP beademing met een frequentie van 0.5 
Hz. Deze beademingstechnieken zijn gebruikt in surfactant deficiente en gezonde 
Iangen. De resultaten van de experimenten geven aan dat bij HFJV van 15 Hz de 
alveolus-capillair membraan de laagste doorlaatbaarheid voor ""'Tc-DTPA heeft. Het 
lijkt erop dat juist deze manier de beste condhies schept voor restauratie van het 
beschadigde surfactant systeem. Daarentegen bleek dat HFJV van 2 Hz uiterst 
schadelijk was voor de Iangen. 
Wanneer het longsurfactant systeem is beschadigd, dan is de permeabiliteit van de 
alveolus-capillair membraan verhoogd voor ssmTc-DTPA. Wanneer er een duidelijke 
relatie is tussen de gemeten permeabiliteit van de alveolus-capillair membraan en het 
surfactant systeem zou het zo moeten zijn dat een toegenomen surfactant 
concentratie in de alveolus een verlaagde gemeten permeabiliteit zou moeten 
opleveren. Deze hypothese is onderzocht in de studie beschreven in hoofds'luk 4. 
De surfactant concentratie is verhoogd d.m.v intraveneuze Ambroxol® toediening of 
intratracheale surfactant toediening. De resultaten van deze studie Iaten inderdaad 
zien dat een toegenomen surfactant concentratie in de alveoli een verlaagde klaring 
van ssmTc-DTPA te zien geeft. 
Bloedgassen zijn belangrijke parameters waarop de arts vaak zijn respiratoire beleid 
afstemt op de I.C.U. Het is natuurlijk de vraag of deze parameters de meest 
gevoelige zijn om een beginnende respiratoire insufficientie of een herstel daarvan 
weer te geven. De studie beschreven in hooldstuk 5 laat zien dat m.b.v bloedgassen 
bij kunstmatige beademing het surfactant systeem niet adequaat beschreven kan 
worden. Terwijl de bloedgassen zich genormaliseerd hadden was de gemeten 
permeabiliteit van de alveolus-capillair membraan nog steeds hoogst abnormaal. 
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De bewezen gevoeligheid van de pulmonale ssmTc-DTPA klaring methode voor 
verander~ngen in de a!veo!us-capmak membraan is aan de ande:s ka:--:·~ cc~( reds~ 
voor vraagtekens om deze techniek voor perrr:eabHlte:tsM<etin;Jen te geb:-~:ke::. Er 
wordt gesuggereerd dat het 99mTc-DTPA-mo:ecuu: te k~e~n ;s vm d:s:;r~r.:ir-:a':1·s 
mogeiijk te maken tussen intermediaire en zware schade aan de aiveoius-cap;Haf;-
membraan. Grotere moleculen, zoals 99~c-gelabelde humaan serum albumi~e (''mTc-
HSA) zouden daarvoor beter geschikt zljn. In hoofdlstuk s wcrdt een s:udle 
beschreven die de pu!mona[e klaring van 99~c-HSA beschrijft ln kon!jnen en waarin 
permeabiliteitsmetingen met 99mTc-HSA worden gerelateerd aan de integriteit van het 
surfactant systeem. Geconcludeerd wordt dat de pulmonale dooriaatbaarheid voor 
ssmTc-HSA gedeeltelijk alhankelijk is van het surfactant systeem: dat de 
doorlaatbaarheld voor dit molecuu! verhoogd is na appficatie van hoge drukken 
beademing bij deze dieren en dat de vorming cq aanwezigheid van longoedeem nog 
onbekende gevolgen heel! voor dit soort metingen. Het gebruik van "mTc-HSA in 
plaats van semTc-DTPA heel! althans in dit stadium nog geen duidelijke voordelen en 
waarschijnlijk is er voor elk molecuul een specifieke gebruikssituatie. 
Een routine-handeling in de hed,endaagse geneeskunde in het toedfenen van 
anaesthesie bij patienten. Hierbij wordt veelvuldig gebruik gemaakt van zgn volatiele 
anaesthesie gassen zoals bijvoorbeeld halothaan die bekend staan om hun mogelijk 
negatieve invloed op het surfactant systeem. In hooldstuk 7 worden de effecten van 
1.0 % halothaan vermengd met 30% en 99% zuurstof gemeten op de permeabiiiteit 
van de alveolus-capillair membraan. Halothaan vermengd met puur zuurstof laat de 
permeabilitelt van deze membraan toenemen, daarmee aangevende dat de 
combinatie van deze twee gassen de structuur van de alveolaire epitheel aantast 
enjol de integriteit van de surfactant laag aanwezig in de alveoli. Dit proces zou een 
rol kunnen spelen bij de ontwikkeling van verschillende per- en post-operatieve I eng 
complicaties zeals atelectasis en pulmonale oedeemvorming. 
In hoofdstuk S wordt een studie beschreven bij rokers en niet-rokers, waarin de 
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integriteit van de alveolus-capillair membraan wordt onderzocht d.m.v. zowel de 
99
"'Tc-DTPA klaring techniek als metingen van de transudatie van albumine en ureum 
in de bronchoalveolaire lavage vloeistof. Het longsurfactant systeem is ook 
onderzocht door metingen van de oppervlakspanning en fosfolipidgehalte in de long 
lavagevloeistof. Het bleek dat met name bij de laatste twee methoden de waarden 
verminderd waren ten opzichte van gezonde niet-rokers. De gemeten 99"'Tc-DTPA 
klaring snelheid correleerde met variabelen van de surfactantfunctie. De toename in 
doorlaatbaarheid van de alveolus-capillair membraan voor 99mTc-DTPA werd niet 
aangetoond voor albumine en ureum. Deze resultaten ondersteunen de hypothese 
dat de toegenomen permeabiliteit voor 99mTc-DTPA in rakers samenhangt met 
veranderingen in de functionele integriteit van het aanwezige surfactant systeem. 
De studies in dit proefschrift tonen het belang aan van het pulmonale surfactant 
systeem voor permeabiliteitsmetingen verricht met 99mTc-gelabelde moleculen zeals 
DTPA en HSA. Deze non-invasieve en simpel uit te voeren techniek is daarom een 
belangrijke nieuwe techniek voor testen van de integriteit van het surfactant systeem. 
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